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ABSTRACT 
Proteins are essential for most biological processes that constitute life. The 
function of a protein is encoded within its 3D folded structure, which is determined by its 
sequence of amino acids. A variation of a single nucleotide in the DNA during 
transcription (nSNV) can alter the amino acid sequence (i.e., a mutation in the protein 
sequence), which can adversely impact protein function and sometimes cause disease. 
These mutations are the most prevalent form of variations in humans, and each individual 
genome harbors tens of thousands of nSNVs that can be benign (neutral) or lead to 
disease. The primary way to assess the impact of nSNVs on function is through 
evolutionary approaches based on positional amino acid conservation. These approaches 
are largely inadequate in the regime where positions evolve at a fast rate. We developed a 
method called dynamic flexibility index (DFI) that measures site-specific conformational 
dynamics of a protein, which is paramount in exploring mechanisms of the impact of 
nSNVs on function. In this thesis, we demonstrate that DFI can distinguish the disease-
associated and neutral nSNVs, particularly for fast evolving positions where evolutionary 
approaches lack predictive power. We also describe an additional dynamics-based metric, 
dynamic coupling index (DCI), which measures the dynamic allosteric residue coupling 
of distal sites on the protein with the functionally critical (i.e., active) sites. Through DCI, 
we analyzed 200 disease mutations of a specific enzyme called GCase, and a proteome-
wide analysis of 75 human enzymes containing 323 neutral and 362 disease mutations. In 
both cases we observed that sites with high dynamic allosteric residue coupling with the 
functional sites (i.e., DARC spots) have an increased susceptibility to harboring disease 
nSNVs. Overall, our comprehensive proteome-wide analysis suggests that incorporating 
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these novel position-specific conformational dynamics based metrics into genomics can 
complement current approaches to increase the accuracy of diagnosing disease nSNVs. 
Furthermore, they provide mechanistic insights about disease development. Lastly, we 
introduce a new, purely sequence-based model that can estimate the dynamics profile of a 
protein by only utilizing coevolution information, eliminating the requirement of the 3D 
structure for determining dynamics.  
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CHAPTER 1 
1 INTRODUCTION 
 
“... If we were to name the most powerful assumption of all, which leads 
one on and on in an attempt to understand life, it is that all things are made 
of atoms, and that everything that living things do can be understood in 
terms of the jiggling and wiggling of atoms.”        
–Richard Feynman, The Feynman Lectures on Physics 
 
 
 
Some parts of this chapter are excerpted from:  
Kumar, A., Butler, B., Kumar, S., and Ozkan, S.B. “Integration of structural dynamics 
and molecular evolution via protein interaction networks: a new era in genomic 
medicine,” Current Opinion in Structural Biology 35, 135-142 (2015). 
 
 The genome contains the blueprints for the synthesis of proteins, which carry out 
crucial biological functions. Protein synthesis occurs in the exome (coding region of the 
genome), in which transcribed DNA (mRNA) is translated on the ribosome to produce a 
chain of amino acids (polypeptide), which then folds into a unique 3D protein structure. 
This tertiary structure is defined by the specific sequence of amino acids. Thus, every 
amino acid sequence encodes a specific 3D protein structure with a particular function. 
This sequence-structure-function relationship has long been at the epicenter of biological 
research. Advanced high-throughput sequencing of individual genomes has led to the 
burgeoning discovery of new sequences, with millions of unique sequences in public 
databases. Moreover, for the past two decades, scientists have been profiling genomic 
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variations in healthy and diseased individuals. These variations are responsible for the 
uniqueness between individual genomes (i.e. variations give rise to differences in the  
 population) according to the Neutral Theory of Molecular Evolution (NTME) (Nei et al., 
2010). Genome-wide association studies, whole-genome sequencing, and exome 
sequencing have shown that each personal genome contains millions of genetic variants, 
thousands of which are related to the development of Mendelian (monogenic) disease or 
complex (polygenic) disease (Hamosh et al., 2005; Green and Guyer, 2011; Stenson et 
al., 2014; Sidore et al., 2015). Thus, interpreting these variants and assessing their 
potential harm is at the forefront of personalized medicine. 
 The different types of genetic variants will be discussed, as depicted in Figure 1.1. 
A single nucleotide variant (SNV) arises when a single nucleotide base in the three-base-
 
Figure 1.1: Types of single nucleotide variants in the genome. Each personal 
genome contains around 3 million single nucleotide variants (SNVs), most of 
which occur in the non-coding region. Comparatively few SNVs are found in the 
coding region due to strong purifying selection effects. Within the coding region, 
SNVs can be synonymous (silent) mutations or non-synonymous (nSNVs) which 
can affect protein function. Most coding SNVs are non-synonymous. In addition, 
non-synonymous SNVs can either be nonsense mutations (i.e. they result in a stop 
codon that halts the synthesis of the protein which can lead to disease) or missense 
mutations, which can lead to the development of various Mendelian or complex 
diseases.  
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pair codon is mutated (e.g. GAG to GTG), which can occur in the coding or non-coding 
region of the genome. In the coding region, the mutated codon can encode a different 
amino acid or the same amino acid. A coding SNV that leads to an amino acid 
substitution is termed a non-synonymous SNV (nSNV), because it results in a different 
polypeptide sequence in its corresponding protein (see Figure 1.2). Conversely, a 
synonymous SNV (silent mutation) does not affect the encoded amino acid due to 
degeneracy in the genetic code (i.e. different codons can code for the same amino acid). 
Generally, most synonymous variants do not lead to harmful phenotypes, and therefore 
are usually considered inconsequential. However, synonymous variants should not be 
overlooked, as they can sometimes impact phenotype by disrupting transcription, 
translation, splicing, or mRNA stability (Chamary et al., 2006; Goymer, 2007; Kimchi-
sarfaty et al., 2007). Moreover, insertions and deletions can also have harmful functional 
effects and play a role in genetic variation (Mullaney et al., 2010). Most emphasis is 
currently on non-synonymous SNVs, which can occur in two different forms. A nonsense 
nSNV leads to a premature stop-codon that obstructs the synthesis of the protein, which 
produces a non-functional protein. Although uncommon, nonsense nSNVs have been 
implicated in several genetic disorders such as the blood disorder Thalassemia (Chang 
and Kan, 1979) and several types of muscular dystrophy (Flanigan et al., 2011). The most 
common non-synonymous variant, a missense nSNV (depicted in Figure 1.2), yields an 
amino acid substitution that results in an altered polypeptide chain. This amino acid 
change can disrupt post-translational modification, protein folding, stability, binding 
affinity, and other functional properties (Katsonis et al., 2014). Thus, missense nSNVs 
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can manifest as disease in humans by producing dysfunctional proteins that lead to 
various ailments. For instance, the genetic disorder Sickle Cell Hemoglobin is attributed  
to a missense variant in the gene that codes for Hemoglobin, the protein responsible for 
carrying oxygen in red blood cells. Figure 1.2A depicts the occurrence of this missense 
variant at the genomic level. A single nucleotide on the DNA template strand is mutated 
from A to T in the codon GAG, yielding a different codon GTG. The codon GTG is 
transcribed on the mRNA strand as GUG. Finally, the codon GUG translates to Valine 
 
Figure 1.2: A missense mutation of the hemoglobin protein that leads to sickle cell 
disease. On the top, the wild type nucleotide base pairs on the original DNA 
template strand (CTC) are transcribed to mRNA, in which the codon GAG (not 
shown here) encodes the amino acid Glutamic Acid (Glu) in the protein sequence. 
At the protein level, this results in normal functional hemoglobin that forms into 
quaternary structures. On the bottom, the mutated DNA contains a missense 
mutation, where a single nucleotide is mutated from T to A in the template 
sequence and A to G in the transcribed mRNA sequence (not shown here). This 
yields a different codon GUG in the transcribed DNA, which encodes a different 
amino acid Valine (Val). This is known as an amino acid substitution caused by a 
non-synonymous single nucleotide variant or nSNV (also referred to as missense 
mutation). The amino acid substitution leads to a new sequence, which expresses as 
a dysfunctional protein that forms clumps and cannot function. [Source: National 
Library of Medicine, National Institutes of Health (left panel) and Understanding 
Evolution. 2016. University of California Museum of Paleontology 
(www.evolution.berkeley.edu) (right panel)]. 
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(Val), which is a different amino acid than without the mutation (wild type). In the wild 
type, the original codon GAG is translated as Glutamic Acid (Glu), which results in the 
normal Hemoglobin protein. This particular amino acid substitution gives rise to the 
disease Sickle Cell Anemia by altering the shape of Hemoglobin, allowing it to form 
aggregates that inhibit its normal function (Figure 1.2B). Indeed, non-synonymous SNVs 
are responsible for at least half of all known Mendelian diseases (Hamosh et al., 2005; 
Stenson et al., 2014). Thus, the challenge is discriminating between nSNVs that will 
severely impact function (deleterious) and those that are benign (neutral). It is now 
established that each personal genome contains tens of thousands of nSNVs, most of 
which are rare (Dudley et al., 2012; Sidore et al., 2015). Deleterious variants are rapidly 
purged from the population through purifying selection before they have the opportunity 
to become fixed (Dudley et al., 2012; Tennessen et al., 2012). That is, variants that cause 
detrimental effects are swiftly eliminated by natural selection in order to preserve the 
population. The frequency of a variant in a population is given by the minor allele 
frequency (MAF), where rare variants have MAF <0.5% and common variants MAF 
>5%. Sorting based on MAF provides a first approximation in isolating potentially 
harmful variants, which typically have MAF <1% (M. X. Li et al., 2012). Analysis of 
genomic data has revealed that nSNVs are highly abundant in the non-coding region and 
less abundant in the coding region (Dudley et al., 2012). Essentially, nSNVs in the highly 
functional coding region are under intense selection pressure, since they are likely to 
impact protein function. For this reason, the coding region is disproportionately skewed 
toward containing rare (MAF <1%) deleterious nSNVs (Marth et al., 2011; Dudley et al., 
2012). The common variants (MAF >5%) in the coding region are usually found to be 
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synonymous SNVs (Dudley et al., 2012). Therefore, predictive studies focus their efforts 
on rare nSNVs, since they represent the strongest candidates for disease development. 
 With the sequencing of each new personal exome, the constellation of known 
nSNVs is expanding at a remarkable rate. But the translation of a personal exome 
variation profile into biomedically relevant information remains a challenge, especially 
since the majority of novel nSNVs are rare and hard to detect (Tennessen et al., 2012; 
Dudley et al., 2012). Multiple databases have been cataloguing human genetic variation 
in a systematic way that can be utilized in functional studies. For instance, The Human 
Gene Mutation Database (HGMD) is a collection of nSNVs that are associated with 
human inherited disease (Stenson et al., 2014). The Online Mendelian Inheritance In 
Man (OMIM) database contains nSNVs related to all known Mendelian disorders 
(Hamosh et al., 2005). The dbSNP database (Sherry et al., 2001) contains population 
nSNVs, including variation data collected from the 1000 Genomes Project (Abecasis et 
al., 2012). The Genome-Wide Associate Studies (GWAS) project has characterized 
thousands of nSNVs that are associated with human disease (M. J. Li et al., 2012). 
Finally, The Cancer Genome Atlas (Chang et al., 2013) and the Catalogue of Somatic 
Mutations In Cancer (COSMIC) (Forbes et al., 2011) are specific to variants associated 
with cancer. Experimental studies that elucidate the functional effects of nSNVs are 
sparse, mainly due to prohibitive cost limitations and time inefficiency. Based upon the 
current wealth of genomic variation data, efficient and reliable in silico tools are needed 
to interpret the effects of nSNVs, which can be integrated into personalized medicine to 
diagnose disease susceptibility. To this aim, computational approaches that leverage 
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genomic variation databases are emerging as the primary way to assess the functional 
impacts of nSNVs. 
 Many computational methods that estimate the effect of nSNVs exploit 
evolutionary information, particularly by using probabilistic scoring functions that 
leverage positional amino acid conservation and/or phylogenetics based on known 
sequences (S. Kumar et al., 2009; Liu et al., 2015). A position that is highly conserved in 
a multiple sequence alignment (MSA) of related homologs is assumed to be essential for 
function, and thus the occurrence of an nSNV at that position is likely to have a severe 
effect. Indeed, it has been evinced that deleterious nSNVs are overabundant at highly 
conserved positions and underabundant at variable positions (Miller and Kumar, 2001; 
Vitkup et al., 2003; Kumar et al., 2011). Some computational methods to predict 
deleterious variants based on evolutionary conservation include SIFT (Ng and Henikoff, 
2003), Gumby (Prabhakar et al., 2006), and GERP++ (Davydov et al., 2010). In addition 
to conservation, sequence-based features such as amino acid physicochemical properties 
(i.e., composition, polarity, and size) is used to quantify the severity of a given amino 
acid change (Grantham, 1974). Amino acid substitutions that are associated with disease 
typically exhibit large physicochemical changes between the wild type and mutant amino 
acid (i.e., radical substitutions), whereas neutral substitutions are less radical (Miller and 
Kumar, 2001; Vitkup et al., 2003). Several approaches use a combination of sequence 
conservation and amino acid physicochemical properties such as MAPP (Stone and 
Sidow, 2005) and Align-GVGD (Tavtigian, 2005). These sequence-based features can 
also be coupled with machine learning algorithms based on training sets to make 
enhanced predictions as in PhD-SNP (Capriotti et al., 2006), Parepro (Tian et al., 2007), 
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and MutationTaster (Schwarz et al., 2010). Although evolutionary conservation has 
proven to be a very effective tool in nSNV diagnosis, it has posed limitations for 
evolutionary methods that are dependent on it. Conservation scores lead to distinguished 
prediction accuracies for damaging nSNVs at highly conserved positions, but the 
accuracies decrease dramatically for damaging nSNVs at variable positions (S. Kumar et 
al., 2009; Kumar et al., 2011). In addition, conservation also struggles to correctly 
identify benign nSNVs at highly conserved positions, since they are presumed to be 
damaging. Moreover, the accuracy of evolutionary conservation also hinges on the ability 
to obtain accurate conservation scores from the multiple sequence alignment, which must 
contain a sufficient number of sequence homologs that are evolutionarily related. Thus, if 
the quality of the sequence alignment is not optimal, the conservation scores may not 
accurately portray the most functionally related positions.  
Beyond the sequence-based methods, there have been many efforts to utilize 
structural properties in the diagnosis of nSNVs. The proliferation of available 
experimental structures in the Protein Data Bank (PDB) (Berman et al., 2000) has 
allowed for the use of structural information to study human disease, especially with 
databases that enable mapping of missense mutations to three-dimensional (3D) 
structures (Luu et al., 2012). As a result, a number of approaches leverage structural 
information to assess the functional effects of missense mutations such as stability, 
binding energy, and solvent accessibility. Stability has been widely used to study the 
effects of mutations. A protein must fold into a stable conformer and adopt a specific 3D 
structure in order to function. Mutations can destabilize a protein by disrupting essential 
interactions such as electrostatic interactions, hydrogen bond networks, binding affinities, 
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and hydrophobic interactions (Steward et al., 2003; Stefl et al., 2013), which can impact 
function in many ways, including obstructing protein folding, promoting aggregation, and 
inhibiting the required formation of protein-protein complexes. Many diseases, including 
Parkinson’s disease, Alzheimer’s disease, and cancer are associated with destabilizing 
missense mutations that inhibit normal protein functions (Stefl et al., 2013; Stehr et al., 
2011; Shi and Moult, 2011; Lori et al., 2013; Grant et al., 2007; Moore et al., 2003). 
Indeed, the majority of mutations involved in Mendelian diseases are destabilizing (Yue 
et al., 2005, 2006; Wang and Moult, 2001), therefore stability is widely used in 
phenotypic prediction studies. The change in stability due to a mutation is quantified as 
the change in folding free energy ∆∆ upon mutation (i.e., ∆∆ = ∆	 − ∆	). This 
can be estimated using molecular dynamics (MD) simulations with a potential energy 
function, although it is computationally expensive and only suitable for small-scale 
studies (Worth et al., 2011). Other in silico tools estimate ∆∆ using statistical/empirical 
potential energy functions based on known structures (Topham et al., 1997; Parthiban et 
al., 2006; Worth et al., 2011; Guerois et al., 2002) or machine learning algorithms based 
on structure and/or sequence (Cheng et al., 2006; Capriotti, Fariselli, and Casadio, 2005; 
Capriotti et al., 2004; Capriotti, Fariselli, Calabrese, et al., 2005), or a combination of 
both (Pires et al., 2014; Dehouck et al., 2011; Masso and Vaisman, 2010). These 
integrated computational approaches are faster and more efficient in stability estimations 
than MD, making them more attractive for large-scale applications in nSNV prediction 
studies. However, recent surveys have revealed that their capacity in diagnosing nSNVs 
are quite limited, with modest accuracies around 60% (Potapov et al., 2009; Khan and 
Vihinen, 2010). Another structural attribute, solvent accessibility, is a scoring metric of 
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sites according to their location on the 3D structure (e.g. buried or exposed) and is used to 
study the functional effect of nSNVs (Dobson et al., 2006; Wei et al., 2012; David et al., 
2012). A review of different structural attributes used in nSNV studies found that the 
feature based on nearest neighbors (13Å structural neighbor profile) was more successful 
at predicting disease association than solvent accessibility, and it was nearly as successful 
as sequence conservation, which emphasizes the importance of microenvironments 
around nSNVs in determining their functional effects (Ye et al., 2007). Some methods 
use machine learning methods to integrate both evolutionary and structural features into 
their approaches such as PolyPhen-2 (Adzhubei et al., 2010), SVM-3D (Capriotti and 
Altman, 2011), SNAP (Bromberg and Rost, 2007), SNPs3D (Yue et al., 2006), and 
nsSNPAnalyzer (Bao et al., 2005). Finally, there are also consensus methods such as 
PredictSNP (Bendl et al., 2014) that classify nSNVs based on the combined results of 
many different prediction methods. The advent of using these structural features 
combined with already successful evolutionary features was optimistically thought to 
lead to advancements in disease prediction accuracies. However, the incorporation of 
structural information has only resulted in a marginal ~4% increase in disease prediction 
accuracies compared to evolutionary methods. This lackluster improvement is primarily 
because of two reasons. First, commonly used structural features (i.e., solvent 
accessibility, structural neighbor profiles, b-factors, and secondary structure) are based on 
a static protein structure and does not account for the intrinsic dynamic motions of a 
protein, which are critical for assessing functional importance. Thus, the inclusion of 
proteins dynamics is paramount in prediction analysis to further improve the accuracies 
of evolutionary methods. Second, proteins do not function in isolation; rather, they 
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interact with each other in order to function, thus, protein-protein interactions should also 
be considered. Although the importance of conformational dynamics is recognized, it has 
not been introduced to genomic analysis due to the lack of position-specific based metrics 
that probe dynamics. Here, we develop a dynamics-based technique to fill this gap.  
In Chapter 2, the methodological details implemented in the work presented thesis 
will be outlined. An in-depth review of the theoretical approaches to investigate 
conformational dynamics of proteins will be presented. Full atomic models such as 
molecular dynamics (MD) and normal mode analysis (NMA) that are based on complex 
empirical potential energy functions will be discussed as well as their limitations and lack 
of applicability to large-scale proteomic studies. Then coarse-grained approaches based 
on elastic network models (ENM) will be discussed, specifically the Gaussian network 
model (GNM), anisotropic network model (ANM), and perturbation response scanning 
(PRS). Their broad range of applicability will be highlighted to motivate their use in the 
proteome-wide studies presented in this thesis, as well as some of their inherent 
limitations. 
Currently, most machine learning methods that utilize structural features are 
based on static 3D structures, which neglect protein conformational dynamics. However, 
protein structure-encoded dynamics, which span a broad timescale of motion from atomic 
fluctuations and side chain rotations to collective domain movements, underlie a protein’s 
biological function. Protein evolution studies of several different protein families have 
shown that changes in conformational dynamics through allosteric regulation lead to new 
functions (e.g., green fluorescent protein (GFP), beta-lactamase inhibitors, and nuclear 
receptors (Glembo et al., 2012; Zou et al., 2015; Kim et al., 2015)). Moreover 
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evolutionary rates are strongly correlated with the flexibility of individual positions 
obtained from conformational dynamics (Nevin Gerek et al., 2013; Liu and Bahar, 2012; 
Liberles et al., 2012). Protein dynamics studies assert that protein function can be 
explained by analyzing the individual contribution of residues to the conformational 
dynamics and stability of a protein (Nevin Gerek et al., 2013; Liu and Bahar, 2012; 
Butler et al., 2015). Therefore, conformational dynamics-based metrics can also be 
utilized in predicting the impact of nSNVs on protein function. Gerek et al. used an 
amino acid site-specific dynamic flexibility index (DFI) metric to evaluate the effect of 
flexibility of individual sites on biological fitness and function. DFI is a position–specific 
metric that quantifies the resilience of each residue to a perturbation occurring at another 
part of the chain (i.e., all other residues in the network), thus identifying the flexible and 
rigid parts of a protein (Nevin Gerek et al., 2013). Analysis of disease-associated and 
neutral nSNVs for more than 100 human proteins revealed that disease-associated nSNVs 
occur predominately at low DFI sites (i.e., rigid hinge sites), signifying the importance of 
hinge sites that control functionally crucial motions. In contrast, neutral variants are more 
abundant at positions with high DFI, suggesting that flexible sites are more robust to 
mutations (Nevin Gerek et al., 2013). Furthermore, DFI profiles of over a thousand sites 
harboring mutations revealed that sites at protein interfaces have lower average DFI than 
those at non-interfaces, suggesting that protein–protein interfaces have less dynamic 
flexibility (Butler et al., 2015). These results suggest that hinge positions at interfaces are 
crucial for binding, thus mutations at these hinge sites will likely be damaging. 
 Another way to assess the phenotypic effects of nSNVs is by considering the 
interactions among protein-protein complexes. A structural mapping of observed nSNVs 
  
13
on human protein–protein interaction (PPI) networks revealed that damaging nSNVs are 
largely found at protein–protein interfaces (Wang et al., 2012). For this reason, some 
methods have focused on modeling interfaces and predicting changes in binding affinities 
to distinguish damaging from benign nSNVs. The proliferation of available experimental 
structures in the Protein Data Bank (Berman et al., 2000) and current advancements in 
homology modeling have facilitated the development of human structural interaction 
network (HSIN) databases of protein–protein and domain–domain interactions (Mosca et 
al., 2012), and mapping nSNVs to three-dimensional (3D) structures (Luu et al., 2012). 
The structural mapping of nSNVs has revealed that nSNVs at interfaces may disrupt or 
enhance protein–protein interactions, thus they are commonly implicated in pathogenesis 
(Schuster-Böckler and Bateman, 2008; David et al., 2012). Similar to core residues, 
interface residues are generally more hydrophobic, thus mutations involving polar or 
charged residues may destabilize important interface interactions necessary for binding 
(Yates and Sternberg, 2013). The loss of obligate electrostatic interactions due to 
interface mutations may lead to complete loss of function of the complex. On the other 
hand, mutations that enhance binding interactions may cause aggregation or aberrant 
recognition, as observed in cancers (Yates and Sternberg, 2013). Because interface 
mutations can drastically affect binding interactions, efforts to predict the effects of 
mutations by measuring the difference between the free energy change upon binding of 
the wild type and the mutant (∆∆) have shown success. Free energy differences upon 
binding calculated via thermodynamic integration and free energy perturbation 
approaches using molecular dynamics (MD) are computationally expensive, particularly 
for large–scale protein complexes. Therefore, in silico tools have been developed as a fast 
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alternative to estimate ∆∆ upon binding using statistical energy functions based on 
known protein structures (Dehouck et al., 2013; Li et al., 2014), empirical force fields 
(Schymkowitz et al., 2005; Guerois et al., 2002), and/or machine learning techniques 
using training sets (Berliner et al., 2014; Zhao et al., 2014). However, the accuracy of 
these calculations are not robust because local structural changes upon mutations are 
generally neglected (Potapov et al., 2009; Khan and Vihinen, 2010). In particular, the 
change in physicochemical properties upon mutation, such as large changes in polarity 
and hydrophobicity, do not significantly alter the binding energy, making it challenging 
to assess nsSNVs (Teng et al., 2009). Evaluating the importance of individual interface 
residues to binding can be used to predict the effect of nsSNVs, as only a small fraction 
of interface residues contribute significantly to binding. Experimental methods to identify 
critical binding sites involve mutating each site to alanine and measuring the 
corresponding change in binding affinity. The sites that contribute the most to binding 
energy are known as hotspots (Bogan and Thorn, 1998). These hotspots are often located 
at highly conserved positions with large changes in accessible surface area (ASA) upon 
binding (Keskin et al., 2008; Tuncbag et al., 2010). Thus, methods to predict hotspot 
residues at binding interfaces are largely based on ASA as in the webserver HotPoint 
(Tuncbag et al., 2010). If an nSNV occurs at a hotspot site, it will likely be damaging 
since it will drastically affect crucial binding interactions. Incorporating hotspots into 
machine learning methods has been successful in predicting disease nSNVs at protein-
protein interfaces (Schuster-Böckler and Bateman, 2008). It remains a challenge to 
predict the effect of interface nSNVs occurring at non-hotspots. 
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 Chapter 3 will provide insight into how conformational dynamics can elucidate 
the mechanism of disease association of nSNVs in protein-protein complexes. We will 
introduce the dynamic flexibility index (DFI) as a tool to estimate site-specific 
conformational dynamics, which is based on the coarse-grained ENM and PRS method 
(discussed in Chapter 2). The majority of proteins must form complexes in order to 
function, thus interfaces residues are critical to the overall stability and function of 
interacting proteins. It was found using DFI that interface sites have lower flexibility 
compared to other parts of the protein, and that nSNVs at these sites are highly 
susceptible to disease. Using DFI, the phenotype of nSNVs at interfaces could be 
discriminated, whereas the static-based metric accessible surface area (ASA) commonly 
employed in evolutionary methods was not indicative of phenotype. Evolutionary 
methods alone are highly suitable for nSNV diagnosis for highly conserved residues, but 
their accuracy is remarkably low for less conserved residues. This weakness indicates a 
necessity for improvement for the purposes of overall more accurate predictions. We will 
show that DFI has the capacity to predict nSNV phenotypes in the less conserved regime, 
where evolutionary methods are inadequate, making it a useful tool that can complement 
existing evolutionary methods and increase overall prediction accuracies. 
 Allostery is the mechanism for regulation of cellular functions through the 
alteration of protein dynamics and structure based on an action at a distant site. Allostery 
is an inherent property in maintaining the function and stability of biomacromolecules, 
thus it is recognized as a crucial factor in disease development and is used to design 
allosteric drugs (Wagner et al., 2016; Nussinov, 2016). Pathogenicity can result from the 
disruption of allosteric regulation in a number of ways. For instance, nSNVs can impair 
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allosteric post-translational modification as observed in driver mutations in cancer 
(Nussinov and Tsai, 2015; Nussinov et al., 2013). Deleterious nSNVs can also change the 
ON/OFF populations in cell signaling by altering the stability of certain conformations 
and/or dynamics. Mutations may lead to disease by shifting allosteric pathways, as 
observed in the nSNV that gives rise to Hyperekplexia (Shan et al., 2012). 
Conformational dynamics is directly connected to allostery in proteins, which was 
evinced by MD simulations and NMR spectroscopy (Guo and Zhou, 2016; Boulton and 
Melacini, 2016; Lisi and Loria, 2016). An MD analysis conducted for disease mutations 
of human ferritin (Kumar, Glembo, et al., 2015) showed that mutations distally located to 
functionally critical sites can allosterically impair hinges of the protein (i.e., rigid parts), 
softening the functionally critical regions, which leads to the loss of allosterically-
regulated conformational dynamics. Allostery also provides a mechanism for the severe 
impact of nSNVs that are located distally to hotspot residues but are dynamically linked 
to hotspots (Tennessen et al., 2012). Hotspots evaluated by the HotPoint server (Tuncbag 
et al., 2010) of the protein complexes in the dataset studied in Butler et al. (Butler et al., 
2015) indicated that most mutations occurring at hotspots are deleterious. However, 
among the hundred deleterious nSNVs at interfaces, only ~50% were located at hotspots. 
This raised the question as to how nSNVs at non-hotspot sites were so significant in 
disease development. This was studied using a new dynamic-based metric called the 
dynamic coupling index (DCI) (Kumar, Glembo, et al., 2015). DCI quantifies the 
resilience of each residue upon the perturbation of only the functionally crucial sites (e.g., 
hotspots, catalytic sites, ligand binding sites). Thus, DCI enables the identification of 
dynamically linked sites that are important for allosteric regulation in the protein. 
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Intriguingly, ~80% of deleterious mutations at non-hotspots exhibited high DCI (i.e., 
strongly dynamically linked to hotspots), indicating that allosteric impairment of the 
hotspot residues resulted in a loss of function.  
 In chapter 4, we will focus on the allosteric impact of nSNVs in enzymatic 
proteins that have known catalytic functions. We will present a case study of the GCase 
protein that is implicated in Gaucher disease. Although it has been well-studied over the 
past century, a plausible mechanism has yet to be firmly established. All-atom molecular 
dynamics (MD) simulations were performed for the native protein as well as 4 known 
mutants in order to elucidate the change in dynamic flexibility (DFI) upon mutation. The 
MD results indicated an overall rigidification of the mutated proteins, including their 
active sites and ligand recognition sites, which are important for enzymatic function. The 
loss of flexibility inhibits the mobility of the ligand recognition sites, making it 
impossible for them to reorient themselves to accommodate binding substrates for 
function. Moreover, when the active sites become exceedingly rigid, their functional 
efficiency is hampered. This provides a mechanism to Gaucher disease, which is 
associated with a loss of catalytic efficiency. In addition, we examine the allosteric 
effects of the 4 mutations, which are distal to the active sites, on global conformational 
dynamics. We implement a new dynamic feature, dynamic coupling index (DCI) that 
measures the resilience of a site to a perturbation at functionally critical residues. The 
results showed a remarkable decrease in allosteric dynamic linking to the active sites for 
each mutation. Each mutation severely impaired the global allosteric coupling to the 
active sites, which altered the conformational dynamics of the protein. This highlights the 
relationship of conformational dynamics and allostery and points to the importance of  
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dynamics in disease development. We extended the analysis to a large and diverse set of 
enzymatic proteins to see if the DFI and DCI metric could be used to diagnose nSNVs on 
a large proteomic scale. Both DFI and DCI were able to distinguish between neutral and 
deleterious nSNVs. Moreover, for a subset of cases where common evolutionary methods 
(i.e., EvoD, PolyPhen-2, and SIFT) misdiagnosed a given nSNV, our dynamics based 
metrics were remarkably effective in diagnosing them with accuracies around 72%. This 
study reveals that protein conformational dynamics can be a complementary feature in 
genomic variation analysis and disease prediction, as also substantiated by the former 
analysis (Chapter 3) and the work of Gerek et. al. 
It has recently become possible to utilize evolutionary sequence variation in 
protein families to examine structural and molecular properties of proteins. Specifically, 
the coevolution of amino acids throughout the evolution of sequences in a family gives 
insight to their relationship in the 3D structure (see Figure 1.3). Amino acid positions that 
exhibit concordant substitution patterns (coevolve) in an alignment of sequence homologs 
 
Figure 1.3: Coevolving residues in two columns of a multiple sequence alignment 
(MSA) (left) are used to infer structural contacts in the tertiary structure (right). 
Evolutionary couplings are often close in proximity in the 3D protein structure. 
They represent an evolutionary constraint on function between similar proteins 
(homologs) in a protein family. From an MSA of a given protein family, the 3D 
structure can be predicted using coevolving residues [Source: (Marks et al., 
2011)]. 
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in a given family are evolutionary couplings (ECs). The degree of coupling is indicative 
of their spatial proximity in the tertiary structure (i.e. strong couplings are representative 
of native 3D contacts). As shown in Figure 1.3, there are two columns i, j where amino 
acids coevolve in the multiple sequence alignment, which serve as an evolutionary 
constraint on function. From this, it can be inferred that these two residues i, j are in 
spatial proximity in the 3D folded structure. This technique is particularly valuable in the 
prediction of non-local contacts where the structure is unknown. The coevolution of 
amino acids from sequences of protein families has been used to successfully reproduce 
known 3D structures (Marks et al., 2011; Morcos et al., 2011) including notoriously 
difficult membrane proteins (Hopf et al., 2012). It has also been used to predict the 
interactions between protein complexes (Hopf et al., 2014). Moreover, coevolution can 
be used to determine important functional sites (Marks et al., 2012), allosteric 
interactions in proteins for drug discovery (Wagner et al., 2016), and functional 
landscapes of complex biomolecules (Jana et al., 2014).   
Chapter 5 will focus on the use of coevolution to approximate the dynamic 
behavior of a protein strictly from protein sequences and no a priori knowledge of the 
structure. Typically a crystal 3D structure must be provided when obtaining the 
conformational dynamics of a protein. In many cases, however, the structure is 
unavailable since there are vastly more known sequences than there are available 
structures in the PDB. To address this, we introduce a new way to obtain approximate 
protein dynamics with only knowledge of a protein sequence. The 3D structural contacts 
are estimated from the co-evolution of residues in a family of protein sequences. Then by 
taking the 3D contacts to be nodes in the Gaussian Network Model (GNM) the 
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vibrational dynamics are calculated from the mean-square fluctuations (B-factors). Using 
3D contacts in known experimental crystal structures, the GNM has been used to 
accurately predict mean-square fluctuations of native proteins. A Kirchhoff matrix is 
formed according to network connectivity, where non-bonded contacts exist between 
residues within a specified cutoff distance surrounding a given residue in the 3D network. 
As an alternative to using the known structure, evolutionary couplings can equally serve 
as non-bonded contacts in the Kirchhoff matrix. The inverse of the Kirchhoff matrix 
yields the theoretical mean-square fluctuation values (B-factors) for each site, which 
compare well to experimental B-factors and those calculated using the known structure. 
Thus, in this novel approach, the protein vibrational dynamics can be explored using 
exclusively sequence information and no a priori knowledge of structure. Given the 
remarkably disproportionate number of sequences available compared to experimental 
structures, this could be an invaluable tool in genomic variation studies that focus on 
disease prediction for proteins that have unknown structures. Moreover, this technique 
can be utilized in aiding in de novo structure prediction and refinement.  
 In short, this thesis will elucidate the potential role of protein conformational 
dynamics in genomic variation analysis. The current methods for diagnosing the 
functional impact of variants are based on evolutionary methods and have well-known 
weaknesses. Therefore, there is clearly a need for improvement in order to optimize the 
accuracy of these diagnosis methods. The evolutionary methods have attempted to 
include structure in their predictions, which resulted in a disappointing ~4% increase in 
accuracy, mainly due to the use of a static protein structure. In this thesis, we show that 
protein conformational dynamics provides insights that cannot be obtained using the 
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static structure and can distinguish between disease and neutral phenotypes of known 
variants. In particular, our dynamics-based metrics have the capacity to diagnose variants 
in the regimes where evolutionary methods are inadequate, which provides another step 
forward in accurate variant diagnosis to assess an individual’s predisposition to disease 
based on their genome. Lastly, the discovery of novel protein sequences continues to 
outpace the experimental determination of 3D crystal protein structures, therefore the use 
of conformational dynamics in genome variation studies is inherently limited. We address 
this dilemma by proposing a new method to approximate protein dynamics using only 
sequence information and no a priori knowledge of the 3D structure. This would extend 
the range of applicability of conformational dynamics to match evolutionary methods that 
also rely on sequence information. The ultimate goal in genomic analysis and 
phylomedicine is to better understand the impact of variants on phenotype in humans and 
assess an individual’s predisposition to disease. The work presented in this thesis will 
make the case that conformational dynamics of proteins can be used in conjunction with 
existing methods to achieve this goal. 
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CHAPTER 2 
 
2 COMPUTATIONAL METHOD FOR STUDYING PROTEIN FUNCTIONAL 
DYNAMICS 
 
2.1 Introduction 
 A myriad of resolved 3D folded protein structures have been characterized and 
deposited in the Protein Data Bank (PDB) (Berman et al., 2000) based on x-ray 
crystallography and NMR experiments. Despite the abundance of known structures, 
leveraging structural information to gain mechanistic insights about how a mutation can 
lead to disease development remains a challenge. Overall, the current methods exploring 
the effect of mutations on a protein employ a static structure, e.g. solvent accessibility, 
which quantifies the amount of solvent that is accessible to the surface (Tsodikov et al., 
2002). While this static-based metric has shown some success in studying the effect of 
mutations due to its simplicity and fast computation (Wei et al., 2012; Adzhubei et al., 
2013), it does not account for the intrinsic dynamics of proteins which is important for 
function. Indeed, the biological function of a protein is based on collective motions that 
sample different conformational states around the equilibrium structure, such as the open 
and closed forms of an enzyme. We devised a dynamic flexibility index (DFI) as a 
measure to explore site-specific dynamics of proteins, and it has been used to elucidate 
the mechanism of disease development (Nevin Gerek et al., 2013; Butler et al., 2015; 
Kumar, Glembo, et al., 2015). DFI uses the coarse-grained technique known as 
Perturbation Response Scanning, which is based on an Elastic Network Model (ENM) 
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and Linear Response Theory. The ENM, while rooted in the classical full-atomistic 
Normal Mode Analysis procedure, is much more computationally efficient and yields 
nearly identical results. In this chapter, the all-atom models of Molecular Dynamics and 
Normal Mode Analysis will be discussed, followed by the detailed formulation of the 
coarse-grained approaches utilizing ENMs: Gaussian Network Model, Anisotropic 
Network Model, and Perturbation Response Scanning. 
 All-atom molecular dynamics (MD) is an atomistic approach that solves 
Newton’s equations of motion for all atoms in a protein using an empirical potential 
energy function (McCammon et al., 1977; Levitt, 1983). MD predicts the intrinsic 
dynamics of a native protein around its equilibrium conformation (i.e., mean-square 
displacement of atoms) and has been widely used over the past 40 years to investigate 
protein dynamics. Despite its success, MD has some limitations: First, it often fails to 
predict large-scale collective motions of globular proteins (e.g. domain movements); 
Second, the complexity of the force fields used to compute equations of motion at the 
atom level make these calculations computationally expensive. These factors impose 
strict limitations on the size of proteins that can be used in MD calculations. Another 
approach to investigate protein dynamics, normal mode analysis (NMA), revealed that 
the low-frequency modes ( < 30 cm-1) are responsible for cooperative motions (i.e., 
functionally-related motions) of a protein and also contribute significantly to the entropy 
of the system, whereas the fast modes correspond to localized movements of few atoms 
and are less crucial for function (Bahar and Rader, 2005; Go et al., 1983; Brooks et al., 
1983; Eyal et al., 2011). NMA has been successfully used predict the mean-square 
displacements in globular proteins, such as the bovine pancreatic trypsin inhibitor (Go et 
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al., 1983). Similar to MD, however, NMA calculations also depend on complicated 
potentials, which impose the same computational restrictions as MD. Moreover, NMA 
yields unstable modes that can be difficult to extract, leading to final configurations often 
disagree with experimental observations (Tirion, 1996).  
Low-frequency modes of motion (soft modes), which usually correspond to 
functional motions, can be found using simplified mechanical models, independently of 
complicated and computationally expensive force-field potentials (Doruker et al., 2000). 
For instance, the dynamics of G-actin found was obtained using a single-parameter 
Hookean potential and turned out to be in close agreement with the dynamics obtained by 
NMA (Tirion, 1996). Subsequently, coarse-grained approaches were developed that 
enjoy simplified potentials to obtain soft mode dynamics such as the Gaussian network 
model (GNM) (Bahar et al., 1997; Haliloglu et al., 1997), the anisotropic network model 
(ANM) (Atilgan et al., 2001), and perturbation response scanning (PRS) (Atilgan and 
Atilgan, 2009; Atilgan et al., 2010; Gerek and Ozkan, 2011). These coarse-grained 
models offer simplicity and fast computational times, yet they can effectively capture 
functional motions due to soft modes independently of complicated empirical potentials 
used MD and NMA (Atilgan et al., 2010; Bahar and Rader, 2005; Cui and Bahar, 2005). 
Moreover, these simplified approaches have made it feasible for computational 
investigations of the dynamics of large proteins (>500 residues) (Hinsen, 1998; Hinsen et 
al., 1999; Tama and Sanejouand, 2001) as well as proteome-wide studies to study the 
functional impact of nSNVs on a wide range of proteins (>100 proteins) (Nevin Gerek et 
al., 2013; Butler et al., 2015; Zheng and Tekpinar, 2009). This chapter will focus on the 
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details of the primary coarse-grained approaches–GNM, ANM, and PRS–and their 
applications in investigating functional protein dynamics. 
2.2 Coarse-grained Approaches 
2.2.1 Gaussian Network Model 
 The Gaussian network model (GNM) is an isotropic model for protein dynamics 
based on contact topology and is rooted in the early work of random polymer networks 
(Flory, 1976; Pearson, 1977; Kloczkowski et al., 1989). The protein is coarse-grained 
such that the C-alpha atoms represent nodes in an elastic network, and the interactions 
between each node is approximated by an elastic spring if the distance between them is 
within a specified cutoff distance. In contrast to the empirical force-field potentials used 
in MD and NMA (Equation 2.1), the pairwise interaction between inter-connected C-
alpha atoms are given by a simple Hookean single-parameter potential (Tirion, 1996) of 
the form 
  = 2  −   (2.1) 
Where  and   are the instantaneous and equilibrium separation vectors between 
connected pairs (see Figure 2.1) and  is a uniform constant. In this topological model, 
sequentially-bonded residues (covalent bonds) are in contact similar to the Rouse chain 
model (Rouse, 1953); in addition, non-bonded residues that are sequentially and spatially 
distant can also be in contact (tertiary contacts) if the distance between them, , is less 
than a specified cut-off distance, . A sufficient cut-off distance for residue contacts was 
determined to be  ≤ 7Å (Bahar et al., 1997). Essentially, an interaction sphere with 
radius  can be imagined to surround a residue i, such that any other residue j within the 
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sphere will be in contact with residue i. A connectivity matrix Γ (Kirchhoff) is then 
constructed as 
 Γ =
 
!−1						$ % &	and	 ≤ 0						i % &	and	 ( − ) Γ,+ 					$ = &
 (2.3) 
Where  is the separation distance between residue pairs i and j, and  is the specified 
cut-off distance (Haliloglu et al., 1997). The Kirchhoff matrix has dimensions , -, 
with N being the total number of C-alpha atoms in the protein. The off-diagonal elements 
of each row are assigned –1 if the pairs are in contact and zero if they are not in contact. 
The diagonal element for each row is found by taking the negative sum of all other 
 
Figure 2.1: Equilibrium fluctuations of C-alpha atoms in the GNM. A section of 
a protein is shown as a dashed line with black dots representing the Cα atoms as 
nodes in the elastic network. The equilibrium position vectors are  and , 
which correspond to two C-alpha atoms i and j. Similarly, their instantaneous 
position vectors are  and . Their separation distance vectors are   (solid 
line) and   (dashed line) respectively. The fluctuation of the equilibrium 
position vectors are . and . in the X, Y, and Z directions between i and j 
and the change in inter-residue distance can be expressed as ∆ =  −  =∆ − ∆. [Source: (Eyal et al., 2011)] 
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elements in that row via the sum Γ = −∑Γ. The diagonal of the Kirchhoff matrix 
represents the local packing density surrounding each residue $ (Bahar et al., 1997; 
Haliloglu et al., 1997; Bagci et al., 2002).  
Residues in the native protein undergo Gaussian-distributed isotropic thermal 
fluctuations about their mean positions given by Δ and Δ as in Figure 2.1 (Bahar et 
al., 1997; Haliloglu et al., 1997). The conformational potential energy of the system is 
then  
 12 = 2 3)Δ − Δ 
2
, 4 = 2 3)ΔΓΔ
2
, 4 (2.4) 
Where  is a uniform constant, Γ is the , -, Kirchhoff matrix, and ∆ is a , - 1 
column vector comprised of all residue fluctuations 5Δ6, Δ, Δ7, … , Δ29 (Eyal et 
al., 2011). It follows that the configurational partition function can be written similarly as 
in the theory of random polymer networks (Flory, 1976; Pearson, 1977; Kloczkowski et 
al., 1989) as  
 :2 = 2;<=>?− @AB⁄ D E5Δ9 (2.5) 
Where V is the GNM potential in Equation 2.4, kB is the Boltzmann constant, T is the 
temperature of the system, and E5Δ9 = 5EΔ6, EΔ, EΔ7, … , EΔ29. The cross-
correlation of fluctuations Δ and Δ between C-alpha atoms i and j is given by their 
statistical ensemble average (Pearson, 1977; Kloczkowski et al., 1989): 
 
〈Δ ⋅ Δ〉 = 1:;Δ ⋅ Δ<=>?− @AB⁄ DE5Δ9	
= I3@AB ⁄ K?ΓL6D (2.6) 
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The mean-square fluctuations of each residue i can be calculated by taking i=j in 
Equation 2.6 as 
 〈Δ ⋅ Δ〉 = 〈IΔK〉 = I3@AB ⁄ K?ΓL6D (2.7) 
 Since the determinant of the Kirchhoff is zero, the inverse Kirchhoff ΓL6 cannot 
be evaluated directly. Instead, the pseudoinverse is evaluated by single value 
decomposition (SVD) using eigenvalues MN and eigenvectors ON of Γ as  
 〈Δ ⋅ Δ〉 = 3@AB ⁄ )?Δ ⋅ ΔDN = 3@AB ⁄ )PMNL6ONONTQ2L6N
2L6
N  (2.8) 
Where the summation is over all , − 1 non-zero modes, k, of Γ (1 ≤ @ ≤ , − 1) 
(Atilgan et al., 2001). The eigenvalues MN and eigenvectors ON, which correspond to the 
frequency and shape of each of the k modes of motion respectively, allow us to analyze 
the form of each mode separately. Particularly, the contribution of correlated motion by 
the kth mode is given by  
 ?Δ ⋅ ΔDN = 3@AB MNL6?OND?OND (2.9) 
Where ?OND is the ith element of ON. A plot of ?OND with respect to residue index i is the 
normalized distribution of mean-square fluctuations in the kth mode (kth mode shape). 
The slowest modes are related to broad collective motions of residues that are usually 
involved principally in biological function. They may be cooperative motions such as 
domain movements to accommodate a substrate or bind to a partner to function. In 
essence, the slow modes represent the most function-related modes. Conversely, the 
fastest modes correspond to highly constrained residues undergoing very small and fast 
movements in their local environment.  
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 The cross-correlation of fluctuations Δ and Δ is the same as in an , - , 
covariance matrix (i.e. R = 〈Δ ⋅ Δ〉), and the largest contribution to the covariance 
comes from the slowest modes (Eyal et al., 2011). Thermal fluctuations in the GNM are 
isotropic such that 
 〈IΔSK〉 = 〈IΔTK〉 = 〈IΔ:K〉 = 〈IΔK〉 3⁄  (2.9) 
And are proportional to the crystallographic B-factors determined by experiment 
 U = 8W3 〈IΔK〉 = 8W@AB ?ΓL6D (2.10) 
Several studies have shown the B-factors predicted by GNM are in good agreement with 
crystallographic B-factors for a diverse set of proteins (Bahar et al., 1997; Haliloglu et 
al., 1997). A proteome-wide analysis by Kundu et al. found that for 113 high-resolution 
structures (resolution <2.0 Å) the B-factors predicted by the GNM correlated 
significantly with observed B-factors (Kundu et al., 2002). Moreover, mean-square 
fluctuations from GNM were also shown to correlate with ANM, MD simulations, 
crystallography, and NMR (Doruker et al., 2000). 
Equations 2.6 and 2.7 yield the magnitude of cross-correlations and mean-square 
fluctuations and, thus, have no direction dependence. The GNM does not require 
directionality or the 3D coordinates of residue displacements – only the contact topology 
of C-alpha atoms (the relative distances between pairs) is necessary to obtain 〈IΔK〉. 
This simplistic model allows for fast, efficient calculations of protein dynamics with 
minimal input. The computational bottleneck of the GNM is inverting the Kirchhoff 
using SVD, which depends on the size of the protein. This still pales in comparison to the 
computational cost of MD or NMA calculations. The GNM describes isotropic 
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fluctuations of the , − 1 modes of motion of a protein in N-dimensional configurational 
space. The incorporation of directional preferences of 3D motion is accounted for in the 
anisotropic network model, which will be elaborated on in the following section.  
2.2.2 Anisotropic Network Model 
The Anisotropic Network Model (ANM) is a coarse-grained approach where a 
protein is viewed as an elastic network model, akin to the GNM described in the previous 
section. Whereas in the GNM all residue fluctuations are isotropic, the ANM differs in 
that it accounts for the 3D directionality of fluctuations (i.e. fluctuations can be 
anisotropic). Therefore the ANM has the capacity to evaluate the 3D character of the 
normal modes of a protein. Consider two interacting residues i and j (Figure 2.1) 
connected by a an elastic spring with the ANM potential 
 
 = 2  −  	
= 2 XYS − S + T − T + : − :[6 ⁄ −  \ 
(2.11) 
Where  is a uniform spring constant and  and   are the instantaneous and 
equilibrium separation between i and j ( =  − ). S, S, T, T, :, and : are the 
vector components of  and  in Figure 2.1. This potential can also be written in terms 
of the network of N residue pairs as 
 
]2 = 2) −   
2
, 	
= 2)YS − S + T − T + : − :[6 ⁄  
2
,  
(2.12) 
  
31
Where   is a Heaviside step function such that   = ^−1						 ≤ 				0						 (  (i.e. 
interacting pairs are assigned −1 whereas non-interacting pairs 0) (Bahar and Rader, 
2005; Atilgan et al., 2001; Tama and Sanejouand, 2001). Alternatively,   can also 
represent an exponential decay function that attenuates with increasing separation 
distance (Hinsen, 1998). For the ANM, a cutoff distance of  = 13Å was found to 
produce the most realistic vibrational frequency distribution (Atilgan et al., 2001). The 
first-order derivative of  with respect to the S component of  in for two interacting 
residues $ and & are 
 
__S = − __S 	
= −S − S1 −  `  (2.13) 
 And the second-order derivative is 
 
__S = __S	
=  Y1 +  S − S 7` −  ` [ 
(2.14) 
Similar equations hold for the T and : components of . At equilibrium,  =   such 
that these equations become  
 
__S = − __S = 0 (2.15) 
 
__S = __S = S − S `  (2.16) 
And similarly the cross-derivatives between the S and T components are 
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__S_T = −S − ST − T `  (2.17) 
When considering all neighbors & of residue $ then the second-order derivatives can be 
expressed as  
 
__S = )S − S	 `  (2.18) 
 
__ST = )S − ST − T `  (2.19) 
 Where the summation is over all neighbors & of residue $. For a protein with , residues, 
the second-order derivatives are stored in a 3, - 3, Hessian matrix a, which has the 
form  
 a = bc66 c6 ⋯ c62c6 c ⋯ c2⋮ ⋱ ⋮c26 c2 ⋯ c22g (2.20) 
Where each super-element c is a 3 - 3 matrix containing all second-order cross-
derivatives given by Equation 2.17 for off-diagonal super-elements c ($ % &) as 
 c =
hii
iii
ij __SS __ST __S:__TS __TT __T:__:S __:T __::kll
lll
lm
 (2.21) 
The diagonal super-elements ($ = &) of a are constructed as 
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 c =
hi
ii
ii
j __S __ST __S:__TS __T __T:__:S __:T __: kl
ll
ll
m
 (2.22) 
Where the diagonal and off-diagonal elements are constructed using Equation 2.18 and 
2.19 respectively. The Hessian matrix in the ANM is analogous to the Kirchhoff matrix 
in the GNM. The single value decomposition of the Hessian results in 3, − 6 non-zero 
eigenvalues MN and eigenvectors ON from which its pseudoinverse can be written as 
 aL6 = ) PMNL6ONONTQ72L6N  (2.23) 
Now the cross-correlations between residue fluctuations in the ANM are calculated as 
 
〈Δ ⋅ Δ〉 = 〈ΔSΔS〉 + 〈ΔTΔT〉 + 〈Δ:Δ:〉	
= @AB Pa7L,7LL6 +a7L6,7L6L6 +a7,7L6 Q (2.24) 
And the mean-square fluctuations are calculated as 
 
〈IΔK〉 = 〈IΔSK〉 + 〈IΔTK〉 + 〈IΔ:K〉	
= @AB Pa7L,7LL6 +a7L6,7L6L6 +a7,7L6 Q (2.25) 
Unlike the GNM, the fluctuations of ΔS, ΔT, and Δ: are treated separately in the ANM 
to account for anisotropy. Similar to the GNM, theoretical B-factors can be calculated in 
the ANM in terms of the inverse Hessian as U = opqNr	7s tuIvL6K. In a study of the w-
amylase inhibitor protein, the 3D molecular motions predicted by ANM correlated well 
with all-atom MD simulations and experiment, which was superior to that of the GNM 
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(Doruker et al., 2000). ANM has been used in multiple studies to probe the directionality 
of collective dynamic motions brought about by the low-frequency modes of proteins. 
For instance, ANM was used to predict fluctuation dynamics of the slow modes of the 
retinol binding protein that correlated with experimental values (Atilgan et al., 2001).  
 The GNM and ANM are both based on elastic networks, and they each have 
applications in which one is more useful over the other. In general, the GNM is preferred 
when seeking the magnitude of fluctuations as well as analyzing the contribution of 
fluctuations to individual modes. Indeed, it has been evinced that B-factors estimated by 
the GNM are more comparable with experimental B-factors than those of ANM (Kundu 
et al., 2002). However, the motions of biomolecules occur in all directions, thus 
incorporating anisotropic effects is important to for gaining mechanistic insights of 
function, particularly when analyzing directional components of motion. ANM accounts 
for the magnitude and direction of fluctuations resulting from the slowest modes, which 
represent an accurate depiction of natural cooperative motions of proteins undergoing 
biological function. Thus analyzing directional motion of biomolecules requires the use 
of ANM instead of the GNM to produce the most realistic model. While both GNM and 
ANM are exponentially less computationally intensive than NMA or MD, GNM offers a 
time-scale advantage over ANM, which only needs to invert a , - , matrix as compared 
to a 3, - 3, matrix. An application of elastic network models to capture the effects of 
external perturbations on a protein structure will be discussed in the following section. 
2.2.3 Perturbation Response Scanning 
The elastic network models (ENM) described above are ways to obtain 
equilibrium fluctuation profiles of proteins by extracting the most essential normal modes 
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(i.e., low-frequency modes). Although they are simple and efficient, they are also 
restrictive since they only measure correlations between residue fluctuations around the 
equilibrium state. Inducing a perturbation in the elastic network and measuring the 
dynamic responses can reveal underlying information about energy landscapes that go 
beyond the equilibrium fluctuations. Thus, several studies have used a modified ENM 
approach in an attempt to measure the effect of perturbing the network, where structural 
perturbations were induced by adjusting the strength of force constants of springs 
between interacting residues (Zheng et al., 2007) or changing the distance between 
interacting residues (Zheng and Brooks, 2005). Another ENM-based technique known as 
Perturbation Response Scanning (PRS) measures the residue fluctuations of the elastic 
network upon perturbation of a single node (i.e., C-alpha atom). This perturbation on a 
node acts to mimic the natural scenario of an approaching ligand exerting a force on the 
binding pocket. Accordingly, its application has been used in a wide range of studies, 
including elucidating mechanisms of ligand binding (Atilgan and Atilgan, 2009), 
binding-induced conformational changes (Atilgan et al., 2010; Bolia and Ozkan, 2016), 
allostery in small PDZ domain proteins (Gerek and Ozkan, 2011), identifying critical 
regions for function/stability (Abdizadeh et al., 2015), and improving flexible docking for 
ligand binding (Bolia and Ozkan, 2016). PRS is a coarse-grained approach in which the 
native protein is modeled as a 3D elastic network (ENM) as described above. A 
perturbation in the form of a random external force (i.e. Brownian kick) is sequentially 
applied on each C-alpha atom in the network (see Figure 2.2). This leads to a cascade of 
perturbations throughout the network, where the resulting displacements of all other 
residues are given by linear response theory. 
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Linear response theory (LRT) was used in structural biology to investigate the 
structural changes of a protein upon ligand binding (Ikeguchi et al., 2005). The theory 
asserts that the mechanical response behavior upon a binding event is linearly related to 
the intrinsic equilibrium fluctuations in the unperturbed state (i.e., unbound ligand-free 
state). Thus, structural changes elicited by such a binding even can be estimated simply 
with the knowledge of the residue cross-fluctuations in the ENM, 〈Δ ⋅ Δ〉. Given an 
external force applied on a residue & in the unperturbed state, the response of another 
residue $ is given by 
 〈∆〉 ≅ 1@AB)〈ΔΔ〉y  (2.26) 
Where 〈ΔΔ〉 is the fluctuation covariance in the unperturbed state, and y is a 
single-vector representing the external force acting on residue & (Ikeguchi et al., 2005). 
The covariance term 〈ΔΔ〉 can be equivalently obtained from either an all-atom MD 
simulation or the inverse Hessian in ENM (Equation 2.23). The structural changes 
predicted by Equation 2.25 is not dependent on the direction or position of the applied 
external force (Ikeguchi et al., 2005), so y is essentially a random external force. The 
approximation of LRT is realistic in the regime where the low-frequency modes of a 
protein contribute the most to conformational changes upon binding; Hence, if faster 
modes contribute more to conformational changes, LRT is not applicable due to 
unrealistically large external forces, y = @AB ∑ 〈∆∆〉L6〈∆〉z  (Yang et al., 2014). 
This is usually not the case, however, since high-frequency modes generally correspond 
to miniscule changes such as side change rotations that do not drastically affect the 
overall structural conformation. Conversely, larger conformational changes that relate to 
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function are almost always due to the low-frequency modes. Thus, the slowest modes 
relevant for function are used to calculate 〈ΔΔ〉 in Equation 2.26 which are 
sufficiently predicted by the ENM.  
 A recent study developed a generalized version of LRT that incorporates time-
dependence (Yang et al., 2014), which can model the mechanical propagation of a force  
throughout the protein (due to ligand binding) as a function of time. The response 
displacement of a residue $ to a constant external force y on a residue & over time is 
 〈∆ItK〉 = 1@AB)P〈ΔI0KΔI0K〉 − 〈ΔItKΔI0K〉Qy  (2.27) 
 
Figure 2.2: A free-body diagram illustrating the Perturbation Response 
Scanning method (PRS). Each sphere contains the pairwise interactions between 
C-alpha atoms (black dots in (A) and grey dots in (B)). The origin is taken to be 
a single residue i, which is connected to other residues j via elastic springs 
(given by Equation 2.1). (A) The unperturbed elastic network where no external 
forces (perturbation) are being applied, and the network is in the equilibrium 
state, where only the internal forces holding the network in equilibrium are at 
play. (B) An external force (perturbation), ∆{|, is applied on residue j resulting 
in a net displacement of all C-alpha atoms from their equilibrium positions (as 
in A). [Source: (Gerek and Ozkan, 2011)] 
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Here, the time-dependent (td-LRT) equation is almost the same as the time-independent 
equation above except for the additional term 〈ΔItKΔI0K〉, which vanishes as t →
∞ and it reduces to time-independent LRT.  
 As mentioned, LRT is used in conjunction with ENM in the PRS approach to 
elucidate conformational motions of proteins. Consider the free-body diagram of C-alpha 
atoms in the PRS model in Figure 2.2 where each C-alpha atom is connected by an elastic 
spring. In the absence of an external force (Figure 2.2A) all of the C-alpha atoms must be 
in equilibrium in accordance with force balance (see equations below). In the case of a 
3D elastic network with , residues (C-alpha atoms) and  interactions between residues 
that are less than the specified cutoff distance , then the force balance is  
 ?D72-?∆yD-6 = 0 (2.28) 
Where  the direction cosine matrix, ∆y contains the internal interaction forces aligned 
in the direction of the bond between two interacting residues (i.e., if a residue has 6 
contacts as in Figure 2.2A, then ∆y is a 6 - 1 column matrix).  
 In the presence of an external force ∆{ as in Figure 2.2B, the nodes of the 
network undergo small displacements away from their original positions. Thus, force 
balance requires that the sum of all the interaction forces be equal to the external applied 
force  
 ?D72-?∆yD-6 = ?∆D72-6 (2.29) 
Where the ∆ matrix contains the components of the applied force acting on a particular 
residue. For a given residue $ the applied force vector is  
 ∆T = P000⋯Δ{Δ{Δ{⋯000Q6-72 (2.30) 
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Where the perturbed residue is ∆ = Δ{Δ{Δ{ and all other residues entries are 
zero. As mentioned, the external force applied to a residue in Figure 2.2B causes a 
positional displacement ∆ of each of the interacting residues from their equilibrium 
positions. Moreover, the distances between each connected residue ∆ (bond distance) 
also change concordantly with ∆, in which their relationship is given by 
 ?TD-72?∆D72-6 = ?∆D-6 (2.31) 
Where T is the transpose of .  
 For an elastic network that consists of nodes that are connected by springs, the 
internal interaction forces between nodes ∆y are related to the bond distances ∆ by 
Hooke’s law as 
 ?D-?∆D-6 = ?∆yD-6 (2.32) 
Where the coefficient matrix  is diagonal. Two different spring constants have been 
devised (Gerek and Ozkan, 2011) to account for bonded interactions, , and non-bonded 
interactions, . For bonded interactions,  = 1, whereas the non-bonded interactions 
between residues $ and & is given by the inverse square of their separation distance  as 
 = 8 ⁄ . Although the original PRS method used uniform spring constants (Atilgan 
and Atilgan, 2009), this can be problematic since the optimal values are different across 
different proteins (Hinsen et al., 2000; Yang et al., 2009). This modified version of PRS 
that delineates between bonded and non-bonded interactions was able to correctly predict 
the conformational changes on a benchmark set of 25 protein structures (Gerek and 
Ozkan, 2011). 
 Upon substituting Equations 2.31 and 2.32 into Equation 2.29, we obtain the 
external forces necessary to induce the sequential displacement of residues  
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 I?D72-?D-?TD-72K?∆D72-6 = ?∆D72-6 (2.33) 
Where T is equivalent to the Hessian matrix a (Atilgan et al., 2001). Finally, to 
calculate the response of individual residues to an applied external force this expression 
can be rearranged as  
 ?∆D72-6 = I?D72-?D-?TD-72KL6?∆D72-6 (2.34) 
And substituting the Hessian for ?D72-?D-?TD-72 Equation 2.34 becomes 
 ?∆D72-6 = ?aD72-72L6 ?∆D72-6 (2.35) 
Which describes the total response displacement of each residue of the protein due to a 
perturbation by an external random force.  
 The Hessian a is obtained from the interactions between C-alpha atoms in the 
coarse-grained ENM in using described in Section 2.2.2 and its inverse is evaluated by 
single value decomposition. Alternatively, aL6 can be replaced by the 3, - 3, 
covariance matrix  as calculated by all-atom MD simulations as 
 ?∆D72-6 = ?D72-72?∆D72-6 (2.36) 
 Which as discussed is computationally intensive to obtain as compared to the coarse-
grained approaches. We primarily use the coarse-grained PRS method to investigate 
protein dynamics for large datasets. However, the PRS method cannot calculate the 
difference between the wild type and mutant forms of a protein (since it is not amino acid 
specific). Thus, to study the changes in dynamics between the wild type and mutant 
forms of the GCase protein (presented in Chapter 4), we will use all-atom MD 
simulations to obtain the covariance matrix and use Equation 2.36 to get the dynamics.  
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CHAPTER 3 
3 CONFORMATIONAL DYNAMICS ON PROTEIN-PROTEIN INTERATIONS 
INFORMS FUNCTIONAL IMPACT OF GENETIC VARIANTS  
 
As excerpted from:  
Butler, B., Gerek Z., Kumar, S., and Ozkan, S.B. “Conformational dynamics of 
nonsynonymous variants at protein interfaces reveals disease association,” Proteins 83: 
3, 428-435 (2015). 
 
3.1 Introduction 
 Advances in sequencing technologies are providing a wealth of data on human 
genetic variation. It is now clear that any personal exome contains thousands of variants, 
the majority of which are non-synonymous single nucleotide variants (nsSNVs) (Kumar 
et al., 2011). However, distinguishing between neutral variants (i.e., those with little or 
no effect on phenotype) from variants associated with disease still remains a major 
challenge for both monogenic (Mendelian) and complex diseases (S. Kumar et al., 2009; 
Kumar et al., 2011). The current state-of-the-art methods for diagnosing amino acid 
variants primarily employ evolutionary information obtained from multispecies sequence 
analysis in a variety of ways (S. Kumar et al., 2009; Kumar et al., 2011; P. Kumar et al., 
2009; Kumar et al., 2012; Dudley et al., 2012; Adzhubei et al., 2010). While these 
methods have been used extensively, they often fail to correctly diagnose damaging 
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variants at evolutionarily variable positions and neutral variants at highly conserved 
positions (S. Kumar et al., 2009). 
 Several methods have been proposed to incorporate structure-based information 
from protein structures. Two prominent methods are to use accessible surface area 
(ASA), which determines the surface area of a protein accessible to a solvent, and the 
change in protein stability, which utilizes the difference in free energy between the folded 
and unfolded state upon mutation through empirical calculation based on the 3-D 
structure (Cline and Karchin, 2010; Cheng et al., 2008; Li et al., 2011; Wei et al., 2012; 
Yue et al., 2005, 2006). Interestingly, the addition of these modalities has only produced 
a marginal 3-4% improvement in the rate of true positive diagnosis (Li et al., 2011; 
Huang, Wang, et al., 2010; Huang, Shi, et al., 2010). A common feature among these 
methods is that they are based on the static 3-D structure of the protein, which fails to 
capture the dynamic motion of the protein structure. From the conformational transitions 
of allosteric proteins to the required flexibility of a ligand-binding site, proteins must 
fluctuate to achieve their function (Zheng et al., 2007; Wang et al., 2004; Velazquez-
Muriel et al., 2009; Tzeng and Kalodimos, 2011; Martin et al., 2012; Liu et al., 2010; 
Liberles et al., 2012; Kalodimos, 2012; Jackson et al., 2009; Glembo et al., 2012; 
Eisenmesser et al., 2005, 2002; Echave and Fernandez, 2009; Echave, 2008; Bhabha et 
al., 2011; Bahar et al., 2010). 
 A reason for the lack of methods incorporating protein dynamics into nsSNV 
diagnoses could be the absence of amino acid site-specific measures that can statistically 
quantify the contribution and impact of each position on the conformational dynamics of 
the protein in a fast and efficient way. We recently developed a dynamic flexibility index 
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(dfi), which measures the contribution of each position to functionally important 
dynamics (Nevin Gerek et al., 2013). Through dfi analyses of more than 100 monomeric 
proteins, we found that the added feature of protein dynamics has the potential to 
distinguish between nsSNVs that impact biological function and those that have no effect 
on function (neutral nsSNVs) at a proteome scale (Nevin Gerek et al., 2013). Moreover, 
this large-scale analysis including population variations implicated in diseases, 
functionally critical positions (catalytic and binding sites), and evolutionary rates of 
substitutions produced concordant patterns; it established that the preservation of 
dynamic properties of residues in a protein structure is critical for maintaining the 
protein/biological function (Nevin Gerek et al., 2013). 
 The dfi metric has not yet been evaluated for biological assemblies. Many 
proteins form biological assemblies in order to perform their specific functions in the cell. 
Recent studies have shown that nsSNVs located at protein-protein interface sites are often 
associated with disease (Wei et al., 2012; David et al., 2012) where additional metrics 
beyond evolutionary information can be useful (Jordan et al., 2010). Therefore, we report 
the dfi analysis for proteins that form biological assemblies and its relationship with 
evolutionary conservation. We also compare the difference between the dfi of disease-
associated and neutral nsSNVs when it is calculated in biological assemblies and when it 
is calculated by using proteins as monomers in order to determine which is more 
informative at phenotypic prediction. Moreover, we compare dfi with the static measure 
of solvent accessible area, which has also been used to predict disease-associated nsSNVs 
in biological assemblies (Wei et al., 2012). 
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3.2 Methods 
3.2.1 Data Set  
 We generated a curated dataset of 1,174 protein nsSNVs using available 
databases, including HumVar that contains 301 disease-associated and 200 neutral 
population variants compiled for PolyPhen-2 (Adzhubei et al., 2010), 383 neutral variants 
from the 1000 Genomes Project with those having population frequency greater than 10% 
(Abecasis et al., 2012), and 290 disease-associated variants from the Human Gene 
Mutation Database (HGMD) (Stenson et al., 2003). The set of 333 unique multimeric 
proteins containing 591 disease-associated and 583 neutral nsSNVs was modeled such 
that all the proteins formed assemblies and have 3-D structures in the Protein Data Bank 
(Bernstein et al., 1977) with >80% sequence identity between the reference sequence and 
experimentally-derived protein structures and >80% sequence coverage using BLAST. 
The high constraints were imposed to ensure that the structures used in this study are real 
experimental human proteins rather than pure homology models. 
3.2.2 The dfi Metric for Biological Assemblies 
 The dynamic flexibility index (dfi) is a metric to determine the structural 
flexibility at specific sites on a protein. We applied our original method (Nevin Gerek et 
al., 2013) directly to biological assemblies (BAs) such that the dynamic flexibility for 
each position in the BA is considered. In brief, the method is based on the perturbation 
response scanning (PRS) method where the equilibrium structure of a protein is 
constructed as a 3-D elastic network model (ENM) in which the nodes are represented by 
C-alpha atoms (Tirion, 1996; Hinsen, 1998), and the pairwise potential between each 
atom is given by the potential of a harmonic spring. A small perturbation in form of 
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random Brownian kick is applied sequentially to each C-alpha atom in the elastic 
network. The perturbation on a single residue results in a cascade of perturbations to all 
other atoms in the network, thus inducing a global response. The fluctuation response 
profile of the positions upon perturbation of a single residue (?∆D72-6) is obtained using 
linear response theory and given by the equation 
 ?∆D72-6 = I?D72-72KL6?∆D72-6 (3.1) 
Where the ∆ vector contains the components of the externally applied random unit force 
vectors (K on the selected residues, and L6is the inverse of Hessian matrix (i.e., , the 
Hessian, is a 3, - 3, matrix composed of the second order derivatives of the harmonic 
potential with respect to the components of the position vectors for the chain of length N).  
To minimize the effects of randomness, this perturbation procedure is performed ten 
times to ensure that the applied force is isotropic with a zero angular average (〈〉 = 0), 
and the response vector ∆  is averaged. 
 In short, the application of the random Brownian kick to a given residue on the 
3D elastic network perturbs the residue interaction network of the protein beyond 
fluctuations inherent in the system at equilibrium and elicits responses from all other 
residues in the structure. Through the perturbation response scanning method (PRS) 
(Gerek and Ozkan, 2011; Atilgan et al., 2001), we compute the fluctuation response of 
residue j, ∆ , both in direction and magnitude upon perturbation. We repeat this 
perturbation on each single residue for all positions in chain and obtain the response 
profiles of all other positions. The dynamic flexibility index, dfi, is then obtained by the 
equation 
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 { = ∑ ∆26 ∑ ∑ |∆|2626  
 
(3.2) 
Where ∆ = 〈∆〉 is the magnitude of positional displacements for residue j in 
response to a perturbation at residue i after averaging out the response vector ∆  over 
ten different random directional unit forces, and N is the total number of positions on the 
biological assembly. Note that we compared the dfi values obtained from the coarse-
grained ENM model with those obtained from all-atom replica exchange molecular 
dynamics simulations for several proteins in our earlier work (Nevin Gerek et al., 2013) 
in which the dfi values obtained from these two different simulation approaches yield 
very high correlations, as Pearson correlation coefficients between PRS and all-atom MD 
ranged from 0.64 to 0.88 for 5 proteins.  
 For the monomeric analysis of biological assemblies, the dfi value is estimated 
using the monomeric unit alone (i.e., for a homomeric dimer with two units of 2N 
residues only the N residue position of the monomeric unit is considered). Thus, the 
impact of the interactions aroused due the interaction of interface residues between each 
unit in the BA is not considered. In estimating the dfi values for the BA, however, the 
whole complex (i.e., 2N residue positions of the two homomeric units) is used such that 
the interactions between the interface positions in the BA are explicitly included in the 
Hessian. Moreover, the flexibility response of residue i on unit 1 after perturbing residue j 
on unit 2 is computed and included in the dfi profile of unit 1. A workflow depicting the 
methodology for the dfi analysis of the BA and monomeric unit is provided in Figure 3.1. 
 Since we collectively analyze atomic positions for a wide variety of protein 
structures, dfi must be normalized. Thus, the dfi value of a specific atomic position in the 
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protein is expressed as %dfi, which is a percentile rank of that atom in a sorted array of 
all dfi values in a given protein. The dfi calculation is performed on each biological 
assembly, which is comprised of two or more chains. The calculation is then done on a 
single chain taken from the biological assembly (Figure 3.1). 
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Figure 3.1: The schematic diagram of the method followed for structural 
dynamics analysis of each multimeric protein. We identify a three-dimensional 
(3-D) structure for each protein sequence through a BLAST search using 
protein data bank (PDB). In this search, the sequence coverage and the 
sequence identity between the reference sequence query and the known protein 
structures is set to >80% and >80%, respectively. The identified 3-D 
experimental structures from PDB are then used for the Perturbation Response 
Scanning (PRS) model to predict the dynamic flexibility index (%dfi) for each 
residue position. 
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3.2.3 Accessible Surface Area (ASA) 
      We compare the dfi metric with a static metric known as accessible surface area 
(ASA) and its capability to quantify phenotypes of nsSNVs. The ASA metric determines 
the amount of surface area in the crystal that is accessible (i.e. exposed to a solvent). We 
calculated ASA by using the DSSP program (Kabsch and Sander, 1983). Following the 
dfi procedure, we normalized ASA values for each residue position and expressed them 
as %ASA. 
3.2.4 Prediction of Interface Sites 
      The prediction of molecular interface residues of BAs were determined using the 
PISA server (Krissinel and Henrick, 2004, 2007, 2005). PISA is a computational tool that 
predicts the strength of interaction between two monomers and the interfaces between 
them, resulting in the multimer that is likely the functional form of the BA. 
3.2.5 Evolutionary Rates 
 We estimate the absolute evolutionary rate at each site by using a previously 
described method (S. Kumar et al., 2009), which computes the number of amino acid 
substitutions in a given phylogeny following the parsimony algorithm for each site 
independently (Fitch, 1971). The evolutionary rate of amino acid changes across species 
is then the number of amino acid substitutions divided by the total time elapsed in the 
tree. Evolutionary rates are in the units of substitutions per amino acid per billion years 
(Byrs) and are based on protein sequence alignments of 46 species available from the 
University of California-Santa Cruz resource (UCSC Human Genome Browser) (Kent et 
al., 2002).  
3.3 Results and Discussion 
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 To assess the effect of using biological assemblies (BAs) on the estimation of 
conformational dynamic parameters, we compared the dfi values of all 1,174 nsSNVs in 
333 BAs with those obtained by using only the monomeric units. Many sites harboring 
sequence variants showed large differences in %dfi calculated from the BA and 
monomeric forms (Figure 3.2A). For example, many high %dfi sites in the  
monomeric calculations show rather low %dfi in the BA calculation. We found many of 
these residues to be located at interface sites in the BA, which seems reasonable since 
residues at interfaces exhibit a different fluctuation profile in assemblies. This is due to 
their interaction with the residues of another unit, unlike the monomeric forms where the 
same residues would interact with a solvent instead. When considering only the interface 
sites (357 of 1,174), we observe a large difference (p < 0.0001) in the cumulative %dfi 
distributions (Figure 3.2B) between the monomeric and multimeric forms with an 
average %dfi of 31% for the BA unit and 51% for the monomeric unit. The interface 
 
Figure 3.2: Distributions of interface and non-interfaces sites in the biological 
assembly proteins and their corresponding monomeric units. A scatter plot is 
shown in (A) of the %dfi values for all variants, disease-associated and neutral, 
using the biological assembly units (y-axis) their corresponding monomeric units 
(x-axis). Each axis is scaled logarithmically. Many sites exhibit low dfi in the BA 
but much higher dfi in their monomers, indicating that they are located at 
interfaces. Cumulative %dfi distributions of interface sites (B) and non-interface 
sites (C) for the BA units and their corresponding monomeric units.  
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variants had lower dynamic flexibility, with over 50% showing %dfi ≤ 25%. This 
tendency is expected since the interactions with other monomeric units in the BA lead to 
a decrease in flexibility. On the other hand, the cumulative %dfi distributions of 
monomeric and BA units are very similar for the nsSNVs at non-interface sites (817 of 
1,174), as shown in Figure 3.2C. For these sites, the average %dfi for BA units was 50% 
and that for their monomeric units was 46%. 
 The above pattern prompted us to investigate whether considering the structural 
dynamics of the BA is more powerful in distinguishing disease-associated nsSNVs. We 
computed the cumulative distributions of 207 disease-associated nsSNVs from 62 
proteins and 150 neutral nsSNVs from 71 proteins separately for interface sites (Figure 
3.3). There is a distinct separation between the two cumulative distributions. At lower dfi, 
the separation of the two curves was pronounced, indicating that sites containing disease-
associated variants have lower dfi than those containing neutral variants at interfaces. The 
 
Figure 3.3: Cumulative %dfi distributions of protein interface sites for disease-
associated variants (black line) and neutral variants (grey line) from the human 
population (compiled from HumVar and the 1000 genomes project). The 
average %dfi for disease-associated variants at interfaces is 23% while that for 
neutral variants is 42% (p < 0.0001). 
  
52
average %dfi for disease-associated variants at interfaces is 23% while that for neutral 
variants is 42% (p < 0.0001). 
 We chose two case studies to shed light on the mechanistic differences for the 
analysis of individual proteins and BAs. Human pyridoxine-5'-phosphate oxidase (1NRG 
in the Protein Data Bank) is a homodimer that serves as an important enzyme to catalyze 
reactions in the vitamin B6 metabolism pathway. Two variants with known disease 
implications from HGMD were mapped onto the protein interface, as shown in Figure 
3.4A. The structure is colored within a spectrum of red–yellow–green–cyan–blue, where 
red shows the highest and blue the lowest values of %dfi. Based on Figure 3.4A, it is 
clear that these two variants located at the interface have low dynamic flexibility (ARG-
95 and ARG-229 have a %dfi of 0.07981 and 0.15962 respectively). With such low dfi 
values those sites are likely critical for function, thus a mutation there will likely lead to a 
 
Figure 3.4: The ribbon diagrams of two proteins containing disease and neutral 
nSNVs given by their dfi profiles. (A) recombinant human pyridoxine-5'-
phosphate oxidase (PDB code: 1NRG) and (B) human carboxypeptidase A1 
(PDB code: 1PYT) with respect to dynamic flexibility index, %dfi, are shown. 
Each structure is colored within a spectrum of red–yellow–green–cyan–blue, 
where red shows the highest (flexible) and blue the lowest values (rigid) of %dfi. 
(A) Two disease-associated variants at interface sites are predicted to be rigid by 
dfi. (B) Two neutral variants at interface sites are predicted to be flexible by dfi. 
The colors of their sticks and spheres correspond to their %dfi. 
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disruption in function. For instance, the site ARG-229 is mutated to TRP-229, which 
results in the potentially fatal disease, neonatal epileptic encephalopathy (NEE) (Stenson 
et al., 2003; Mills et al., 2005). For the second case, three neutral variants from the 1000 
Genomes Project were mapped to the model structure of human carboxypeptidase A1 
(homologous structure is 1PYT in the Protein Data Bank) with TYR-435 occurring at an 
interface site and the other two at non-interface sites (Figure 3.4B). From Figure 3.4B, it 
can be seen that these sites have noticeably higher dynamic flexibility. Interestingly, even 
TYR-435 had a high dfi score of 0.62084 despite its location at an interface. It is expected 
that interface sites generally have lower dfi values since they are interacting with residues 
of another protein, thus high dfi at an interface is surprising and could lend useful 
information relating to the phenotype. Fig. 3.4 shows how variants within an individual 
protein could lead to the general trend seen in Figure 3.3, which is based on the analysis 
of more than 100 proteins. Moreover, the trend exhibited in Figure 3.3 and the case study 
presented in Figure 3.4 together gives further indication to the notion that dfi may 
discriminate disease-associated from neutral variants. 
 For comparison, we also examined the performance of ASA, a metric based on 
the static form of the protein structure, which has also been utilized to differentiate 
disease-associated nsSNVs from neutral variants (Jordan et al., 2010; Franzosa and Xia, 
2009; Wei et al., 2012). We found that the average %ASA showed only a small 
difference (45% for disease-associated and 66% for neutral population variants), as 
compared to a 2.5 times difference observed for average %dfi (21% for disease associated 
and 54% for neutral population variants). We found that there is a correlation between 
ASA and dfi, as sites with low ASA that are surrounded with other residues rather than 
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solvent would exhibit fewer fluctuations and cause lower dfi values. However, among 
these low ASA positions, certain positions can be more dynamically critical in translating 
or controlling the functionally related motion than others due to their residue interaction 
pattern within the protein structure. By utilizing dfi, we are able to capture these 
dynamically critical positions. Thus, the above result suggests that the interface residues 
that play an important role in the collective motion of the BA are more susceptible to 
damaging mutations. 
 We examine whether the predictive capabilities of dfi for the BA go beyond that 
afforded by evolutionary conservation of positions involved by estimating the 
evolutionary rate (r) for each nsSNV site (as described in the methods section). We 
divided the estimated evolutionary rate (r) into two different categories: ultra-conserved 
(r = 0) or less-conserved (r > 0).  In our analysis, 37% of interface sites and 30% non-
interface sites were ultra-conserved sites. Likewise, 63% of interface sites and 70% of 
non-interface sites were less-conserved sites. This difference in evolutionary rates is 
rather small, as compared to conformational dynamics where a higher fraction of 
interface sites have very low dfi (53% of interface sites and 29% non-interface have dfi ≤ 
25%). This prompted us to consider the phenotypic prediction of nsSNVs at interface 
sites, as the ability to correctly identify disease associated variation at less-conserved 
sites is not high for many evolutionary rate based in silico prediction tools (S. Kumar et 
al., 2009; Kumar et al., 2011) and many interface sites are at less conserved positions. 
We surmised that dfi calculated using BAs might provide information beyond that 
afforded by evolutionary conservation at those sites. Thus, we explored the ability of dfi 
to discriminate disease-associated and neutral nsSNVs at less-conserved sites (r > 0). 
  
55
 We compared box plots of %dfi and %ASA for disease-associated and neutral 
variants at interface sites that were less-conserved (Figure 3.5A). Remarkably, the 
average %dfi of disease-associated nsSNVs is approximately 2.5 times lower than that of  
neutral nsSNVs gathered from human population statistics (Adzhubei et al., 2010). The 
average %dfi for disease-associated variants was 25% at less-conserved sites at 
interfaces, whereas the average %dfi for neutral variants from the 1000 Genomes Project 
and HumVar was 45% (p < 0.001 when comparing both datasets). This suggests that dfi 
is likely a useful metric for predicting phenotypes of nsSNVs at less-conserved sites. In 
comparison, we did not see a suggestive difference in ASA between neutral and disease-
associated variants, as the average %ASA for disease-associated sites was 47% at less-
conserved interface sites, whereas the average %ASA for neutral sites was 52% (p = 0.63 
for disease vs. 1000 Genomes Project and HumVar). We then conducted a receiver 
 
Figure 3.5: A box plot of %dfi (green) and %ASA (brown) distributions comparing 
disease-associated and neutral nsSNVs for less-conserved variants (evolutionary 
rate r > 0) occurring at protein interfaces. Box plots show median, upper, and 
lower quartiles, and whiskers represent maximum and minimum values. (B) A 
receiver operating characteristics (ROC) curve for dfi and ASA using a test set that 
was generated from 10% of the whole data set. The area under the curve (AUC) for 
dfi and ASA was 0.71 and 0.56 respectively. TPR and FPR are true and false 
positive rates in predicting disease associated nsSNVs to be identified as non-
neutral, respectively. 
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operating characteristics (ROC) curve analysis for %dfi and %ASA to elucidate their 
ability to distinguish between disease and neutral phenotypes of nsSNVs. A randomly 
generated test set consisting of 10% of the entire data set (which only includes nsSNVs at 
interfaces) was used and the remaining 90% was used for training (Stone, 2014; Kumar et 
al., 2012). The area under the curve (AUC) for dfi is 0.71 and 0.56 for ASA (Figure 
3.5B). Therefore, the use of dfi appears to be advantageous for use in future diagnostic 
methods. 
3.4 Conclusion 
      This work has provided evidence that non-synonymous variants observed at protein 
interface sites with low dfi are more likely to be disease-associated. This may be due to 
the fact that protein interface sites with low dfi play a critical role in modulating the 
functionally important inter-dynamics of biological assemblies. Indeed, evolutionary 
based metrics as well as proteins’ static structure based metrics such as ASA have unique 
strengths in predicting the phenotypic impact, thus incorporating metrics based on 
structural dynamics (such as dfi) along with other metrics may increase the prediction 
accuracy of phenotypes of interface nsSNVs. 
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CHAPTER 4 
4 DYNAMICS AND ALLOSTERY IN GENETIC ANALYSIS OF ENZYMES 
 
As excerpted from:  
Butler, B., Kumar, A., and Ozkan, S.B. “DARC spots: dynamic allosteric residue 
coupling reveals disease mechanism for Gaucher disease and nSNVs across the 
proteome,” Nature Communications, Submitted. 
 
4.1 Introduction 
 Advancements in genome sequencing have led to an exponential growth in the 
number of known non-synonymous single nucleotide variants (nSNVs). Each individual 
genome contains millions of variants, many of which are rare nSNVs (Kumar et al., 
2011). Further, variations in exomes (protein coding regions) have been associated with 
more than a thousand major diseases (Kumar, Butler, et al., 2015; Nussinov and Tsai, 
2013; S. Kumar et al., 2009; Kumar et al., 2011). The grand challenge has been 
transforming exome variation data into biomedically relevant information that informs 
actionable treatment recommendations. The amount of nSNV data found through 
genome-wide association studies, whole-genome sequencing, and exome sequencing has 
led to a vast array of computational techniques that leverage evolutionary, biophysical, 
structural, and dynamics information to assess the impact of nSNVs on protein function 
and, thus, phenotypic expression. However, despite these prodigious efforts, explicitly 
defining the relationships between disease and nSNVs, estimating the level of risk of a 
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given individual, and elucidating the underlying molecular mechanisms remains a hurdle 
yet to be surmounted (Kumar, Butler, et al., 2015; Nussinov and Tsai, 2013; S. Kumar et 
al., 2009; Kumar et al., 2011). 
 Shedding light on the molecular mechanisms of missense nSNVs is particularly 
crucial; the manner in which missense variants impact protein function enables us to 
correctly identify a causal relationship between specific variations and disease 
contributions. Moreover, a better understanding of these mechanisms can potentially 
provide novel therapeutic strategies. It is known that disease-associated variants alter the 
stability of a protein (Guerois et al., 2002; Alber, 1989; Yue et al., 2005). Conversely, a 
recent study based on high-throughput functional assays of over 2000 variants revealed 
that only one-third of mutations led to a decrease in protein stability (Sahni et al., 2015). 
Rather than affecting stability, disrupting binding or both, a large fraction of disease-
associated variants impair protein-ligand function or enzymatic activity (Butler et al., 
2015; Kumar, Butler, et al., 2015; Wang et al., 2012). Additionally, disease-associated 
variants are not always located at highly conserved (i.e., functionally critical) positions. 
Since current state-of-the-art methods focus or even rely on assessing these conserved 
positions, they often fail to accurately diagnose variants at non-conserved positions (S. 
Kumar et al., 2009). To confound the problem, studies that combine evolutionary 
approaches with biochemistry for protein design have also revealed disease-causing 
mutations at non-conserved sites can involve very complex and poorly understood 
mechanisms. The basic evolutionary principle that biochemically similar substitutions on 
non-conserved sites do not alter function does not necessarily hold. On the contrary, 
regardless of biochemical similarity, amino acid substitutions at non-conserved sites lead 
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to a wide-range of outcomes, increasing or decreasing functional activity at up to three 
orders of magnitude (i.e., rheostatic pattern of change) (Swint-Kruse, 2016).  
 Conformational dynamics of proteins are essential to explain the complexity of 
functional responses upon an amino acid substitution. In proteins, all positions are 
dynamically linked to each other within a network, where the strength of each link varies 
across the protein. These intrinsic dynamics are structure-encoded and govern protein 
function (Haliloglu and Bahar, 2015). The obsolete view of the single native structure has 
been long replaced by “an ensemble of substates” that accurately represent the native 
state (Tawfik and Tokuriki, 2009). In the ensemble model, a protein samples a variety of 
conformations through local changes such as loop motions, side-chain rotations, or global 
changes through domain rearrangement. Allostery, commonly known as regulation at a 
distance, is a widely used emergent property of this ensemble view. Rather than forming 
a new structure, a ligand binding to a remote site promotes a shift in dynamics, changing 
the intrinsic structure-encoded dynamics and dynamic linking (i.e., distribution of 
accessible conformational states in the ensemble), promoting easy access to certain 
conformers for allosteric regulations (Nussinov and Tsai, 2013; Guo and Zhou, 2016; 
Woldeyes et al., 2014). Furthermore, the ensemble view also agrees with the evolutionary 
adaptability of a protein in which the same conserved 3D native fold can adopt new 
functions (Haliloglu and Bahar, 2015). Mutations throughout protein evolution alter 
conformational dynamics, shifting the distribution of the ensemble and lead to the 
emergence of new functions (Zou et al., 2015; Kim et al., 2015; Glembo et al., 2012; 
Bhabha et al., 2013; Campbell et al., 2016) and adaption to different environments (Villy 
Isaksen et al., 2016). 
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 The importance of protein structure-encoded dynamics in allostery, evolution, and 
disease, prompted the recently developed position-specific metric, dynamic flexibility 
index (DFI) that can statistically measure the functional contribution and impact of each 
amino acid position on structural dynamics. DFI quantifies the resilience of a given 
position to the perturbations that occur at different parts of the protein using linear 
response theory, capturing the multi-dimensional effects when the protein structure is 
displaced out of equilibrium and identifies flexible and rigid positions in the structure 
(Nevin Gerek et al., 2013; Butler et al., 2015). DFI can be considered a measure of the 
local conformational entropy of a given position within the set of interactions governed 
by the 3D fold of the protein due to its ability to probe the conformational space of a 
protein at the residue level. A DFI analysis on the evolution of different protein families, 
including green fluorescence proteins (GFP) (Kim et al., 2015) and beta-lactamase 
inhibitors (Zou et al., 2015), has revealed that mutations of conserved regions observed 
during evolution alter the local flexibility/rigidity of different parts of the structure;  this 
leads to changes in structure-encoded dynamics and the emergence of new biological 
functions. A proteome-wide conformational dynamics analysis of over 100 human 
proteins showed strong correlations between DFI profiles and corresponding evolutionary 
rates of individual positions (Nevin Gerek et al., 2013). Another analysis of DFI profiles 
of the wild type light chain subunit of the human ferritin protein along with its neutral 
and disease forms revealed that neutral variants exhibit similar DFI profiles to the wild 
type, in which experimentally-determined critical functional sites act as hinges (i.e., sites 
with low flexibility) for controlling global motions. However, the disease mutations 
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caused these hinges to become loose (i.e., increased flexibility), impairing the structural 
dynamics and function of the protein (Kumar, Glembo, et al., 2015). 
 The present study focuses on disease nSNVs occurring in human enzymes that are 
commonly misdiagnosed by machine learning approaches based on evolutionary 
principles. The misdiagnosed nSNVs are usually at non-conserved sites, distal to catalytic 
sites, yet they impair enzymatic function and lead to disease phenotypes. Our earlier 
studies suggested that conformational dynamics might provide insights for these cases 
(Kumar, Glembo, et al., 2015; Butler et al., 2015). We investigated the dynamic allosteric 
coupling of disease sites with the catalytic sites using our dynamic coupling index (DCI) 
metric. DCI can identify dynamic allosteric residue coupling sites (DARC spots), which 
are strongly coupled to active sites that are critical for function. A mutation at a DARC 
spot likely influences the conformational dynamics and allosteric regulation and thus, is 
highly susceptible to disease phenotype.    
 One of the signature human enzymes with over 200 disease-associated nSNVs is 
β-Glucocerebrosidase (GCase). Missense mutations in the GCase lead to Gaucher disease 
(GD) (Lieberman, 2011). GD is a human catabolic disorder that leads to a buildup of its 
substrate Glucocerebroside (GlcCer). The buildup of GlcCer leads to “Gaucher cells” 
which result in enlarged organs, splenomegaly, hepatomegaly and, in severe cases, 
central nervous system disorders (Hruska et al., 2008). GD was first discovered by 
Philippe Gaucher in 1882 while treating a woman with an enlarged spleen, and is highly 
prevalent in the Ashkenazi Jewish population (Beutler et al., 1993; Hruska et al., 2008). 
Most of the mutations are far from functional catalytic sites but still impact enzymatic 
rates (Lieberman, 2011). We focused on four specific disease mutations—H255Q (Stone 
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et al., 2000), M123V (Finn et al., 2000), V375L (Finn et al., 2000) and N370S 
(Lieberman et al., 2007)—where the common prediction servers (e.g., PolyPhen-2 and 
SIFT) misdiagnosed them as benign. These disease mutations are shown to be expressible 
in a stable, folded protein, yet the catalytic activity of the protein is significantly reduced. 
Previous GD studies have catalogued mutations that have genotypic and phenotypic 
correlations (Beutler et al., 2005; Hruska et al., 2008). However, few studies investigated 
the mechanistic impact of these mutations on conformational dynamics and allosteric 
regulation (Lieberman et al., 2007).  
 Here we report a case study of GCase, which revealed that GD mutations disrupt 
allosteric regulation due to changes in dynamic flexibility around the catalytic sites, 
thereby impacting the function of the enzyme. Thus, the disease mutation sites manifest 
as key dynamic allosteric coupling sites (i.e., DARC spots). The results indicate that DFI 
can identify sites in GCase where mutations have a severe functional impact. To further 
study the role of dynamics and allostery in missense variants, we conducted a proteome-
wide DFI analysis on a set of enzymes showed that DFI is a robust predictor of the 
impact of nSNVs and is complementary to established evolutionary metrics.   
4.2 Results  
4.2.1 Missense Variants of GCase 
 Over a century of research on Gaucher Disease (GD) has provided an extensive 
catalogue of missense mutations of GCase that lead to the disruption of the enzymatic 
function of the protein. GCase is a member of the family of glycoside hydrolases that 
uses catalytic glutamates for general acid/base hydrolysis. Specifically, GCase 
hydrolyzes its primary substrate, glucocerebrosidase, into glucose and ceramide, and its  
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secondary substrate glucosphingosine, into glucose and sphingosine. GCase (PDB code: 
1OGS) is a 497-residue protein that consists of three domains. As Figure 4.1 shows, the 
first domain (residues 1-85) is an anti-parallel β-sheet (red); the second domain (residues 
86-424) is a TIM barrel that contains the active site (blue); the third domain (residues 
425-497) is a β-barrel (green). The active site consists of two residues, Glu235 and 
Glu340 obtained from the Catalytic Site Atlas (Porter et al., 2004). Residues that line the 
glucose-binding region are Arg120, Asp127, Phe128, Trp179, Asn234, Tyr244, Phe246, 
Try313, Cys342, Ser345, Trp381, Asn396, Phe397, and Val398. The aromatic residues 
are important for ligand recognition and the polar residues stabilize the substrate through 
the formation of hydrogen bonds (Henrissat, 1991). 
 
Figure 4.1: Structure and active region of GCase (A) Ribbon diagram of GCase 
(PDB code: 1OGS), an enzyme whose malfunction leads to Gaucher Disease 
(GD). GCase is a member of the family of glycoside hydrolases that use 
glutamates for hydrolyzing glucocerebrosidase into glucose and ceramide. It is 
comprised of three domains. The first domain (red) is an anti-parallel βpsheet; the 
second domain (blue) is a TIM barrel that contains the active site. The third 
domain (green) is a βpbarrel. (B) A close-up view of the active region contained 
in the second domain including the two catalytic sites; the catalytic sites Glu235 
and Glu340 are shown as grey spheres. 
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 Despite the identification of over 200 GD-associated missense mutations, there is 
little mechanistic insight as to how these mutations disrupt the function of GCase 
(Beutler et al., 2005; Sidransky, 2004; Grabowski, 2004; Germain, 2004; Lieberman et 
al., 2007). Determining the mechanism of GD is confounded by the anomaly that GCase 
with a GD-associated mutation is expressed as a stable protein, yet the catalytic activity is 
reduced. We address this by investigating the role of conformational dynamics in GCase 
by using the dynamic flexibility index (DFI). The DFI method utilizes the perturbation 
response scanning method (PRS) (Nevin Gerek et al., 2013) that couples linear response 
theory (Ikeguchi et al., 2005) along with the covariance matrix of the C-alpha atoms 
obtained from molecular dynamics simulations or an elastic network model. The method 
consists of applying a random Brownian kick as a mechanical perturbation to a single 
residue, and then computing the fluctuation response profile of all other residues in the 
network to this perturbation. Repeating this random perturbation sequentially for each 
site, we are able to compute the normalized response profile (i.e., DFI score) for every 
residue in the protein. The residues with low DFI indicate dynamic stability; they can 
absorb and transfer a perturbation throughout the chain in a cascade fashion. Low DFI 
positions will often be the hinge parts of the protein that control critical functional 
motions, similar to joints in a skeleton (i.e., the motion of a forearm is only possible by 
the elbow acting as a hinge). Conversely, sites with high DFI are more susceptible to 
perturbations in the amino acid chain. They are structurally flexible sites and important 
for biochemical function (e.g., anchoring sites during binding or signaling). DFI can, 
therefore, elucidate the mechanism of missense mutations by measuring changes in 
conformational dynamics and dynamic allosteric coupling. 
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 The mutant forms of GCase include a neutral mutation, Q169R, and four disease 
mutations that are shown to produce structurally stable proteins (Beutler et al., 2005; 
Sidransky, 2004). The four disease-associated mutations, H255Q (Stone et al., 2000), 
M123V (Finn et al., 2000),V375L (Finn et al., 2000) and N370S (Lieberman et al., 
2007). M123V, V375L and N370S, lead to mild type I GD, which is the most frequent 
non-neuropathic form of the disease (Sidransky, 2004); H255G leads to severe type II 
GD which results in traumatic and rapid neurological devastation (Sidransky, 2004). The 
neutral mutation, Q169R, and the disease mutations—H255Q, M123V, V375L—were 
found in the HumVar database (Adzhubei et al., 2010). These disease mutations provided 
an excellent test set, as evolution-based servers have misdiagnosed them as neutral. The 
mutant forms were modeled using the mutagenesis wizard in PyMol (Schrodinger, 2010) 
and the wild type crystal structure was obtained from the Protein Data Bank (PDB code: 
1OGS). The N370S mutation was chosen for two reasons. First, this mutation is 
commonly found in approximately 70% of the Ashkenazi Jewish population and has been 
extensively studied (Lieberman et al., 2007). Second, it is not necessary to model this 
mutant structure like the other variants since the crystal structure of the N370S mutant is 
available (PDB code: 3KE0). This allows us to compare the native equilibrium dynamics 
of N370S using the crystal structure as the initial structure for the simulation with the 
modeled mutant structures of the other mutations to verify the efficacy of the models.  
 The spatial distance of each disease mutation to a catalytic site was determined by 
computing the distances between their respective C-alpha atoms. All four mutations were 
found to be located remotely from the active site of GCase with distances ranging from  
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12.2Å to 22.2Å (Figure 4.2A). This rules out the possibility that direct interactions with 
the active site disrupted the function upon mutation.  
4.2.2 Disease Mutations Alter Conformational Dynamics 
 The decreased enzymatic activity upon mutation suggests that the mutation sites 
are allosterically coupled to the catalytic sites (Glu235 and Glu340). To verify this, we 
computed the dynamic coupling index (DCI) scores for each site, which is a site-specific 
metric that quantifies the degree of dynamic allosteric residue coupling with specified  
 
Figure 4.2: Disease mutations of GCase. (A) The positions of the four disease 
mutations (red sticks)—M123V, H255G, V375L, and N370S—are mapped onto 
the crystal structure of GCase (PDB code: 1OGS). The mutations M123V, V375L, 
and N370S are known to lead to mild type I Gaucher Disease while H255G leads 
to severe type II Gaucher Disease. The catalytic sites are shown as gray spheres. 
The distance between the C-alpha atom of each mutation site and the catalytic sites 
are labeled with a yellow dashed line. The large distances, ranging from 12.2–
22.2Å, indicate that mutation sites are not in direct interaction (i.e., van der Walls 
interaction) with the catalytic sites. (B) A ribbon diagram of GCase is colored 
according to its DCI profile. The DCI metric measures the dynamic allosteric 
residue coupling to functional residues, which here are the catalytic sites (grey 
spheres). Positions in red are highly coupled to the catalytic sites, whereas 
positions in blue are weakly coupled to the catalytic sites. The disease mutations 
(yellow, orange, and red sticks) are strongly coupled to the active site. 
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sites that are critical for function (e.g., active sites such as catalytic residues). Essentially, 
it measures the change in the response fluctuation profile of a site upon perturbing only  
functional sites as compared to the average response profile of perturbing all sites. Sites 
distal to the active sites that exhibit high DCI values are DARC spots (i.e., dynamic 
allosteric residue coupling spots), and a mutation there would likely also impact the 
active sites. Figure 4.2B presents a ribbon diagram of GCase colored according to its DCI 
profile from a spectrum of red-orange-yellow-green-cyan-blue, where red indicates sites 
that are strongly coupled to the catalytic sites (high DCI), whereas sites in blue are 
weakly coupled (low DCI). The disease mutations exhibit high DCI (yellow/orange), 
indicating they are dynamically linked to the catalytic sites. In addition to these four 
disease mutations, we also computed the distance of 84 other missense GD mutations 
 
Figure 4.3: The probability distribution of the minimum distances to nearest 
catalytic sites (u ) of the disease sites exhibiting %DCI >0.5 (i.e., highly 
coupled). The minimum distance, u, is the distance of a given nSNV site to the 
closest catalytic based on their relative C-alpha positions. The distribution of 
disease nSNVs shows that over 80% are distally located to catalytic sites, which 
indicates that they are dynamically coupled (DARC spots) important for allosteric 
regulation. 
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(categorized as severe impact (Beutler et al., 2005)) from the catalytic sites and compared 
this to their respective DCI scores. Approximately 80% of the disease mutations that 
exhibited high DCI (>0.5) were not in direct contact with the catalytic sites (See Figure  
4.3). This highlights the role of dynamic allosteric residue coupling between mutation 
sites and catalytic sites, which suggests that mutations at DARC spots alter 
conformational dynamics at catalytic sites, leading to suppression of enzymatic activity in 
GCase (Sinha and Nussinov, 2001).   
 To further elucidate the change in conformational dynamics upon mutation, we 
obtained DFI profiles of each mutant form and compared them with that of the wild type. 
The average DFI profile of the disease mutants differs from the wild type, particularly in 
the first and second domains (TIM barrel) where the catalytic site exhibits lower DFI 
values at specific locations (Figure 4.4A). Our earlier analysis on ancestral proteins and 
proteome-wide analysis of missense variants suggests that the distribution of rigid and 
flexible parts of the proteins and their communication through dynamic allosteric 
coupling channels underlies the function of the protein (Glembo et al., 2012; Zou et al., 
2015; Kumar, Butler, et al., 2015). The change in the average DFI profile of disease 
mutants compared to the wild type agrees with our earlier findings that the selected 
mutations allosterically affect conformational dynamics (Kumar, Glembo, et al., 2015). 
Specifically, mutations not only affect conformational dynamics of sites within the 
vicinity of mutation, but also affect the dynamics of distal sites through dynamic 
allosteric coupling. 
 Figure 4.4A shows the average DFI profile of the four disease mutants (red) as 
compared to the wild type (black). There is an appreciable decrease in the DFI profile of  
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Figure 4.4: DFI profile of disease mutants. (A) The DFI profile of the wild type 
(black) and average DFI of disease mutants (red). Residues exhibiting high DFI are 
the most flexible parts of the protein, whereas residues with low DFI are the most 
rigid parts of the protein. The average disease profile is significantly different than 
the wild type indicating that the disease variants rigidified at specific regions of the 
protein. (B) The color-coded ribbon diagrams of GCase using pDFI ([DFIdisease – 
DFIwt] / DFIwt) profiles for each disease mutant, where red indicates an increase in 
the flexibility of the residue upon mutation; blue indicates a decrease in the 
flexibility. The catalytic residues at the active site are shown as spheres. The 
residues represented as sticks are key sites in binding recognition and ligand 
stability. Overall, all disease mutants show a rigidification around the active site 
suggesting alteration of ligand binding rates as a plausible mechanism. (C) The 
color-coded ribbon diagram of loop1 based on pDFI for the disease mutant 
N370S, which shows an increase in flexibility of loop1 (red). 
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mutants compared to wild type in three regions. Interestingly, the first region, residues 
59-65, includes the glycosylation site N60 (Figure 4.4A) which is known to be critical for 
enzymatic function (Pol-Fachin et al., 2016). It follows that a drastic decrease in the  
flexibility of this position as exhibited in disease mutants may interfere with 
glycosylation. The functional role of the other two regions, 187-190 and 405-409  (Figure 
4.4A) are not known. However, the mutation D409H is a unique case where a an 
intracellular change in GCase activity generates a phenotypic response, including specific 
cardiovascular symptoms (Pasmanik-Chor et al., 1996). Likewise, region 187-190, 
includes position N188 where the atypical mutation N188S is associated with myoclonic 
epilepsy (Kowarz et al., 2005) due to decrease of functional activity in GCase (Tajima et 
al., 2010). 
 We further quantified the change in flexibility per position upon a disease 
mutation by computing the fractional change in DFI as ΔDFI ([DFIdisease  – DFIwt] / 
DFIwt) with particular interest in positions identified as binding and recognition sites near 
catalytic sites. In Figure 4.4B ribbon diagrams of the mutant structures are color-coded 
according to their ΔDFI profiles for each disease mutant. Regions that exhibit a large 
decrease in DFI as compared to the wild type become more rigid upon mutation (blue). 
Interestingly, Figure 4.4B shows that each mutant structure shows a consistent trend 
where disease mutations lead to the rigidification of the two catalytic sites. Moreover, 
most of the positions critical for ligand binding and recognition (shown as sticks in 
Figure 4.4B) exhibit a large decrease in DFI, suggesting that the decreased flexibility 
may impair catalytic turnover rates in enzymatic function. 
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 Among the 5 loops surrounding the active site, we observe that loop1 (312-317) 
and loop4 (237-248) exhibit an increase in DFI (Figure 4.4A), suggesting that increased 
flexibility of these loops could contribute to the decrease in enzymatic activity by 
hindering the accessibility of the ligand to the active site as observed in previous work 
(Li et al., 2015). In accordance with work of Liebermen et al (Lieberman et al., 2007), 
the N370S mutant shows the most drastic increase in DFI of loop1 (Figure 4.4C). Based 
on crystal structures of IFG bound N370S, unbound N370S and wild type, it was 
proposed that binding of IFG to loop1 of the N370S mutant leads to increased enzymatic 
efficiency and trafficking due to stabilization of loop1, locking GCase into a substrate-
bound conformation (Lieberman et al., 2007). The increase flexibility of loop1 in N370S 
allows conformations where Tyr313 would hydrogen bind to Glu235, hindering the 
accessibility of substrate to the active site (Lieberman et al., 2007). Indeed, Figure 4.4C 
shows a notable increase in flexibility of Tyr313 and Phe316 (i.e., the positions where 
IGF binds and stabilizes).  
 In summary, the change in DFI profiles of disease mutants provides an 
explanation as to why the mutant forms are expressed as stable proteins yet have 
decreased enzymatic activity. The disease mutations lead to a protein where certain 
regions (binding and recognition sites) become highly rigid while other regions (loop1 
and loop4) exhibit enhanced flexibility. Importantly, the flexibility was restricted to only 
these localized changes, as a global increase in flexibility would likely lead to a drastic 
destabilization of the enzyme. Therefore, the disease mutants are still stable enough to be 
expressed. In addition to increased flexibility of loop1 and loop4, we also observed 
decreased flexibility of ligand recognition sites in disease mutants as compared to the 
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wild type, which suggests another possible mechanism: when the orientations of 
recognition and binding sites become restricted, they lose the required flexibility 
necessary to accommodate the ligand binding event. This may lead to decreased catalytic 
turnover rates of the enzyme and obstruct enzymatic function. Furthermore, these results 
show an allosteric mechanism in which mutation sites that are not in direct contact (i.e., 
Van der Waals interactions) with the critical functional sites could still alter their 
conformational dynamics. 
4.2.3 Loss of Dynamic Allosteric Coupling in Missense Variants 
 In general, GCase is a large protein with three domains, where dynamic allosteric 
coupling between residues in different domains, beyond the TIM Barrel active region, 
likely plays a role in overall function for this enzyme. Indeed it has been shown that 
interaction with Saposin C (SapC) is critical for GCase activity by remodeling the lipid 
membrane, presumably by helping GCase access the short head group of the lipid 
bilayers (Qin, 1996). Thus, dynamic allosteric coupling between the catalytic domain and 
the other two domains of GCase should play a key role in regulation of enzymatic 
function. We further investigated how dynamic coupling of each position to the two 
catalytic sites (E235 and E340) changes upon disease mutation using the dynamic 
coupling index (DCI). Here, we use DCI to determine whether or not disease sites are 
DARC spots, and if mutations at DARC spots impair the long-range dynamic coupling of 
catalytic sites to the rest of the chain. Interestingly, the DCI profiles of all four disease 
mutants showed a drastic decrease in dynamic allosteric residue coupling as shown in 
Figure 4.5A. It is remarkable that all disease mutants lead to a global loss of dynamic 
coupling with the two active site positions due to changes in dynamic flexibility, 
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particularly with the decreased flexibility of critical positions (i.e., binding recognition 
sites) near the catalytic sites. We further analyzed the fractional change in dynamic 
coupling of the catalytic sites as upon disease mutation compared to the wild type as 
ΔDCI ([DCIdisease – DCIwt] / DCIwt). Figure 4.5B shows ribbon diagrams of the mutant 
structures color-coded according to their ΔDCI profiles for each disease mutant. Regions  
 
Figure 4.5: DCI profiles of disease mutants. (A) The DCI profile of the wild type 
(black) and disease mutants—H255Q (red), M123V (blue), V375L (green), N370S 
(purple). The DCI metric measures the dynamic allosteric residue coupling to 
functionally critical residues in a protein, which in this case are the catalytic 
residues Glu235 and Glu340. Residues with high DCI values are strongly coupled 
to the catalytic sites; residues with low DCI values are weakly coupled to the 
catalytic sites. All disease mutants show a global loss in dynamic coupling to the 
catalytic sites. This global loss of allosteric coupling disrupts any allosteric 
pathway involved in the regulation and function of the protein. (B) A ribbon 
diagram of the disease mutants colored according to ΔDCI ([DCIdisease – DCIwt] / 
DCIwt). The catalytic sites are colored as grey spheres. The positions in red indicate 
an increase in dynamic coupling upon mutation as compared to the wild type. The 
positions in blue indicate a decrease in dynamic coupling upon mutation as 
compared to the wild type. All residues involved in ligand binding have decreased 
ΔDCI profiles, indicating a loss in allosteric coupling with the catalytic sites and a 
loss in allosteric regulation for enzyme catalysis.  
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that exhibit a large decrease in DCI as compared to the wild type become less coupled to 
the catalytic sites upon mutation (blue). The ΔDCI of all binding sites showed a severe 
loss in dynamic coupling to catalytic sites. These results suggest a plausible disease 
mechanism: a loss in dynamic coupling with catalytic sites, particularly binding 
recognition sites, can explain the drastic decrease in catalytic activity of GCase in disease 
mutants. It is worth noting that the modeled disease mutants exhibit similar DFI and DCI  
profiles with the N370S mutant in which the available crystal structure was used (PDB 
code: 3KE0), suggesting that the equilibrium dynamics of the modeled structures are 
reasonable and give consistent results with the simulation of the N370S crystal structure. 
 We did further analysis by comparing the DFI profiles of the neutral mutation, 
Q169R (found in the Humvar Dataset (Adzhubei et al., 2010)), to the disease mutation 
M123V. The Q169R mutation is accepted as neutral putatively due to its prevalence in a 
large portion of the human population and thus has not been associated with the disease. 
However, this must be taken with caution since recent studies have reported that variants 
 
Figure 4.6: Ribbon diagram of the ΔDFI profile of the Q169R neutral mutation 
compared to the M123V disease mutation. The neutral mutation Q169R shows a 
slight decrease in the flexibility of the active site and residues involved in binding, 
however the degree of rigidification is significantly less than that of the disease 
variant M123V. 
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often observed in healthy individuals can still be weakly disruptive for molecular 
function (Bromberg et al., 2013). The ΔDFI profile of Q169R indicates that the dynamics 
are only slightly altered as compared to a much more significant change exhibited in 
M123V (Figure 4.6). In particular, the sites critical for binding and recognition show a 
minimal change in dynamics in Q169R as compared to those in M123V, which exhibits a 
large decrease in flexibility. This evidence further substantiates our proposed mechanism  
that local changes in dynamic flexibility due to a mutation disrupts critical dynamic 
allosteric residue coupling with the catalytic sites, hampering catalytic activity. 
 
Figure 4.7: Observed-to-expected ratio of severe Gaucher Disease mutations. 
The expected set is the dynamic coupling index (%DCI) distribution of all 
residues in the protein. The observed set is the %DCI distribution of all 
residues associated with a severe type II Gaucher Disease missense mutation 
(Beutler et al., 2005). The observed-to-expected ratio of %DCI shows that 
severe mutations are abundantly found at high %DCI, which are sites 
allosterically coupled to catalytic residues and disproportionately not found at 
sites of low %DCI. A mutation at high %DCI sites will allosterically impact 
the dynamics of functional sites, leading to disruption in dynamic coupling and 
decreased enzymatic activity. 
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4.2.4 A Majority of GD Variants at DARC Spots 
 Given the observation that the four disease mutations are allosterically coupled to 
the catalytic sites and lead to changes in DFI profiles of positions at distal sites in GCase, 
we speculated that this may be a general trend in 84 missense variants in GCase 
categorized as severe Type II GD (Beutler et al., 2005). The DCI values were ranked into 
percentiles (%DCI) and sorted into bins of .10. The observed-to-expected ratio of %DCI 
values were computed, where the expected values were based on the %DCI distribution 
of all sites in GCase, and the observed values were the %DCI values of the 84 mutations. 
Under the null hypothesis of no effect, the ratio of the expected and observed numbers of 
sites hosting disease mutations should be close to 1.0 for each %DCI bin. A strong 
relationship between severe mutation sites and dynamic allosteric coupling with the 
active site (i.e., those exhibiting high DCI) would reject the null hypothesis that disease 
mutations are distributed uniformly in sites with low and high dynamic coupling. This 
null hypothesis was rejected in our analysis (p <0.046). Figure 4.7 shows the observed-
to-expected ratio of %DCI which indicates that severe disease mutations are 
overabundant at high %DCI sites (%DCI value of 0.8-1.0) with values greater than 1.0. 
This evinces that mutations at DARC spots likely impact function, leading to disease 
phenotypes.  
4.2.5 Proteome-wide Analysis: Conformational Dynamics and DARC Spots 
 The role of site-specific structure-encoded dynamics was first demonstrated in a 
proteome-wide study using a dataset of Mendelian diseases, which revealed the 
correlation between the dynamic flexibility index (DFI) of residues in monomeric 
proteins and the biological phenotype of nSNVs (Nevin Gerek et al., 2013). A subsequent 
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study demonstrated the efficacy of DFI in analyzing the impact of nSNVs in biological 
assemblies (Butler et al., 2015). These studies confirmed the utility of structural 
dynamics-based measures as a way to predict the functional impact of nSNVs across the 
proteome. Here we investigated the role of dynamic allosteric residue coupling with 
catalytic sites in human enzymes. We computed DFI and DCI profiles for 75 monomeric 
enzymes containing 685 missense mutations in which the phenotype was known (See  
 Methods for the dataset). The DFI and DCI profile of each protein was converted to a 
percent ranking, %DFI and %DCI, so that the values could be compared across different 
proteins. As Figure 4.8A shows, the %DFI distribution for the 362 disease mutations  
exhibits a distinctly opposite trend as compared to the 323 neutral mutations (p <0.0001), 
in agreement with our previous findings (Butler et al., 2015; Kumar, Butler, et al., 2015). 
The average %DFI for disease variants is 0.37 while that for neutral variants is 0.6, 
quantifying the validity of DFI as a measure of the functional and biological impact of 
mutations. 
 
Figure 4.8: DFI and DCI distributions of nSNVs in a proteome-wide analysis of 
conformational dynamics of nSNVs. The %DFI distribution (A) and %DCI 
distribution (B) of 362 disease variants and 323 neutral variants expressed as a 
probability mass function (PMF). A student t-test comparing the disease and neutral 
distributions revealed a significant difference for both %DFI and %DCI (p 
<0.0001). 
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 We also calculated dynamic coupling index (DCI) profiles for the enzymes in our 
data set to measure the dynamic allosteric residue coupling of mutation sites to catalytic 
sites. A given mutation may not occur at a hinge (i.e., low %DFI sites) but can be 
strongly coupled to, and thus dynamically alter, a catalytic site from distances of over 
10Å. The DCI metric can, therefore, identify disease mutations that may have otherwise 
been overlooked by DFI. A mutation at a site that is highly coupled to an active site 
(%DCI >0.6) is a DARC spot that will likely disrupt function and lead to a disease 
phenotype. Figure 4.8B shows the %DCI distributions of 362 disease and 323 neutral 
mutations, which show opposite trends (p <0.0001). As expected, the frequency of 
disease variants begins to increase sharply for %DCI >0.6, confirming that sites highly 
coupled to catalytic sites are likely to be disease-associated. Some neutral mutations (i.e., 
abundant in human population) were also found at DARC spots, which suggests the 
possibility that substitutions at these positions may still impact function, being mildly 
disruptive as implied by other approaches (Bromberg et al., 2013; Reeb et al., 2016). The 
DCI metric is particularly useful for two reasons: first, it can discriminate between 
disease and neutral phenotypes for mutations that are not spatially close to active sites. 
Second, it can be used in conjunction with DFI to ascertain likely disease mutations with 
increased prediction accuracy.  
 Computational methods for diagnosing phenotypic effects of mutations (e.g., 
EvoD (Kumar et al., 2012), PolyPhen-2 (Adzhubei et al., 2013), SIFT (Ng and Henikoff, 
2003), PhD-SNP (Capriotti et al., 2006), PANTHER (Thomas et al., 2003), MutPred (Li 
et al., 2009), SNPs&GO (Calabrese et al., 2009), SNAP (Bromberg and Rost, 2007) and 
nsSNPAnalyzer (Bao et al., 2005)) can achieve accuracies between 70-80% on 
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independent, non-trained datasets. These metrics, which are largely based on 
evolutionary information such as conservation, tend to fail for disease variants at highly 
variable positions and benign variants at highly conserved positions (Kumar et al., 2011; 
S. Kumar et al., 2009). Thus, we further explored whether dynamics can be used as a 
complementary feature to evolution. From our original dataset we selected all instances 
where at least one evolutionary method misdiagnosed an nSNV phenotype (i.e., EvoD, 
PolyPhen-2, Sift). This subset of data was divided into 90% training and 10% test sets 
where the features %DFI and %DCI were used to train a logistic regression model to 
predict whether an nSNV was deleterious or neutral. We evaluated the performance of  
 
Figure 4.9: An ROC Curve for evolutionary misdiagnosed variants. From the dataset 
we selected all instances where at least one evolutionary method misdiagnosed 
nSNV phenotype (i.e., EvoD, PolyPhen-2, Sift). The dataset was divided into 90% 
training and 10% test sets and the features %DFI and %DCI were used to train a 
logistic regression model to predict whether an nSNV was deleterious or neutral. We 
evaluated the performance of our model by calculating an ROC curve, which yields 
an area under the curve (AUC) of 0.879, indicating that DFI and DCI are superior 
predictive metrics where evolutionary methods are deficient. Thus, dynamics can 
complement evolutionary methods in disease classification to obtain overall better 
results. A 5-fold and 10-fold cross-validation was also performed and shown in 
supplementary Figure 4.10. 
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our model by calculating an ROC curve (Figure 4.9), which yielded an area under the 
curve (AUC) of 0.879, indicating that DFI and DCI are predictive metrics and can 
complement evolutionary methods in classifying nSNVs. Furthermore, a 5-fold and 10-
fold cross-validation analysis resulted in a mean AUC of 0.79 and 0.77 respectively 
(Figure 4.10). These results suggest that dynamics-based metrics such as DFI and DCI 
can provide complementary information that can assist evolution-based models, 
particularly in the regime where they lack predictive ability.  
4.3 Discussion 
 Previous analysis of our work and that of others has demonstrated the important 
role of conformational dynamics in the emergence of new functions from protein  
 
Figure 4.10: A K-fold stratified cross-validation plot. From the dataset we selected 
all instances where at least one evolutionary method misdiagnosed nSNV phenotype 
of a variant (i.e., EvoD, PolyPhen-2, Sift). A stratified K-fold cross-validation was 
performed in which our dynamics-based features DFI and DCI were used to train a 
logistic regression model to predict whether an nSNV was deleterious or neutral. (A) 
In a 5-fold cross-validation the AUC ranged from 0.74 to 0.84 with a mean AUC of 
0.79. (B) In a 10-fold cross-validation the AUC ranged from 0.71 to 0.85 with a 
mean AUC of 0.77. This indicates that DFI and DCI are robust predictors for cases 
where the evolutionary methods are lacking in predictive power. 
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evolution (Zou et al., 2015; Kim et al., 2015; Glembo et al., 2012; Bhabha et al., 2013; 
Campbell et al., 2016; Kumar, Glembo, et al., 2015; Kumar, Butler, et al., 2015; Butler et 
al., 2015; Nevin Gerek et al., 2013). Our site-specific DFI analysis revealed that amino 
acid substitutions alter the flexibility/rigidity of various regions within a given protein, 
leading to the emergence of new functions. Additionally, DFI analysis of protein 
evolution showed that sites subject to drastic flexibility change during evolution are not 
the actual mutational sites but at sites distal to these mutations, indicating allosteric 
regulations play a role in protein evolution. For instance, the emergence of red-emitting 
proteins is achieved by 13 mutations of the least-evolved green fluorescence ancestor 
protein. While DFI profiles of these mutations do not significantly change, this 
distributed set of mutations on GFP causes enhanced flexibility of several positions near 
the chromophore that propagates throughout the protein, ultimately converging on a 
distant location for compensatory stiffening (Kim et al., 2015).  
 If nature uses dynamic allosteric residue coupling for the emergence of new 
functions it follows that disease mutations could exploit the same mechanism for disease 
pathogeny. Here we explored the mechanistic role conformational dynamics in human 
disease. In particular, we focused on how disease mutations influence protein dynamics, 
whether they impair critical allosteric residue couplings to catalytic sites and, 
subsequently, their impact on enzymatic function. We first analyzed the missense 
variants associated with GD. There are over 200 missense variants frequently observed in 
human populations that drastically decrease the enzymatic function of GCase and lead to 
different GD phenotypes (Hruska et al., 2008). Interestingly, we have found a majority of 
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disease mutations occur at DARC spots, meaning they have long-range dynamic coupling 
to the catalytic sites.  
 We did a rigorous evaluation of four disease variants that are often misdiagnosed 
as neutral in many evolution-based prediction methods. DFI profiles of GD mutations 
show a significant change in flexibility/rigidity profiles as compared to the wild type. In 
agreement with the earlier work of Liebermen et al (Lieberman et al., 2007) disease 
variants, particularly N370S, exhibited an increased flexibility of both loop1 and loop4 
and a decrease in flexibility of the sites involved in binding; both changes could interfere 
with enzymatic function. Overall, this analysis shows that mutations remotely alter the 
flexibility of the regions critical for the enzymatic function, a phenomenon we also 
observed in the emergence of new functions in protein evolution. Furthermore, disease 
mutations also lead to loss in dynamic allosteric coupling of the catalytic site with the rest 
of protein. This results in a global affect on the protein’s allosteric network and may 
significantly impact enzymatic function. As discussed in a review (Gunasekaran et al., 
2004), allostery is a common property among all proteins and is necessary for enzymatic 
function. In GCase, this network disruption could interfere with communication between 
the enzymatic domain and SapC interacting domains. In previous work we also observed 
how disease mutations altered the dynamic coupling of the functional loop in human 
ferritin (Kumar, Glembo, et al., 2015; Kumar, Butler, et al., 2015). 
 Lastly, we conducted a proteome-wide analysis of 75 monomeric human enzymes 
to investigate the role of conformational dynamics and dynamic allosteric residue 
coupling. To our knowledge, this is the first proteome-wide analysis of disease mutations 
in enzymes. We observed the same trend as seen in missense disease variants of GCase. 
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Compared to neutral mutations, most of the disease mutations occurred at low DFI 
positions and/or have high DCI values indicating they are DARC spots. Interestingly, 
when we focused on cases that are challenging to correctly diagnose by evolution-based 
prediction methods, we observed that DFI and DCI was able to complement these 
methods and correctly predict at least 70% of misdiagnosed missense variants.  
 To summarize, we are in the era of rapid development of next-generation methods 
for whole-genome, whole-exome, and targeted sequencing that has generated an 
unprecedented amount of data. Among all the variation data, the most commonly 
observed variants are nSNVs, and identifying the nSNVs with pathogenic effects that 
contribute to disease or drug sensitivities is the primary goal of 21st century genomic 
analysis and phylomedicine. As stated in a review of allostery by Liu and Nussinov (Liu 
and Nussinov, 2016),  uniting the genetic code, which constitutes “the first secret of life,” 
and allostery, “the second secret of life,” could reveal a generalized disease mechanism 
and allow for discovery of novel drugs, as well as the blueprints for deeply innovative 
personalized treatment methods. 
4.4 Methods  
4.4.1 Dataset 
 A total of 75 individual monomeric protein structures from the Protein Data Bank 
(PDB) (Berman et al., 2000) were collected from a BLAST search of sequences with 
requirements of ≥80% sequence identity and ≥80% query coverage to ensure only 
structures that could be accurately mapped to human variation data were included. 
Human genetic variations were obtained from the HumVar and HumDiv databases 
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(Adzhubei et al., 2010) with a total of 685 non-synonymous single nucleotide variants 
(nSNVs), where 323 were neutral and 362 were deleterious.  
4.4.2 Determining Catalytic Sites 
 The catalytic sites were gathered from the Catalytic Site Atlas (CSA) database 
(Furnham et al., 2014) which identifies the residues that are directly involved in 
catalyzing the reactions of enzymes. Since these residues are critical for protein function, 
they were used as input into our dynamic coupling index (DCI) metric. The entries in the 
CSA were either “original entries” derived from the literature itself or “homology 
entries” based on sequence comparison with the literature-based original entries. In either 
case, the catalytic sites purported by the CSA should accurately represent functional sites 
on the protein. Our dataset contained 75 enzymatic proteins that mapped to entries in the 
CSA database.  
4.4.3 Calculating Functional-dynamics Profiles 
 The method for obtaining the dynamic flexibility index (DFI) is based on the 
perturbation response scanning (PRS) method (Atilgan and Atilgan, 2009), in which the 
C-alpha atom of each residue in the protein is modeled as a node in an elastic network 
model (ENM). The interaction between each node is modeled by a harmonic potential 
with a distance-dependent spring constant (Atilgan and Atilgan, 2009; Atilgan et al., 
2001). A small perturbation in the form of an external random force (i.e., Brownian kick) 
is sequentially applied on each node in the network and the perturbation response of all 
nodes is recorded according to linear response theory as 
 ?∆D72-6 = ?aD72-72L6 ?∆D72-6 
 
(4.1) 
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Where  is the external random force, aL is the inverse Hessian, and ∆ is the 
positional displacement of all N nodes in three dimensions. Each perturbation is 
performed in ten different directions to ensure an isotropic response. The perturbation is 
repeated for every node in the network, and the positional displacements ∆ of each node 
are stored in a perturbation matrix  given by 
 ?D2-2 =
hi
ii
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 (4.2) 
Where ∆ = 〈∆〉 is the magnitude of the positional displacement of each residue i 
in response to a perturbation at residue j. The DFI score of residue i is defined as the sum 
of the total displacement of residue i induced by a perturbation on all residues, which is 
computed by taking the sum of the ith row of the perturbation matrix A, 
 { = ∑ ∆26 ∑ ∑ |∆|2626  
 
(4.3) 
Where the denominator is the total displacement of all residues, used as a normalizing 
factor. 
 Recently, we have extended this method to identify allosteric links or dynamic 
coupling between any given residue and functionally important residues by introducing a 
new metric called the dynamic coupling index (DCI) (Kumar, Glembo, et al., 2015). The 
DCI metric can identify DARC spots, which are sites that are distal to functional sites but 
control them through dynamic allosteric coupling. This type of allosteric coupling is 
important; sites with strong dynamic allosteric coupling to functionally critical residues 
(DARC spots), regardless of separation distance, likely contribute to the function as well. 
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Thus, a mutation at such a site can disrupt the allosteric dynamic coupling or regulation, 
leading to functional degradation. As defined, DCI is the ratio of the sum of the mean 
square fluctuation response of the residue i upon functional site perturbations (i.e., 
catalytic residues) to the response of residue i upon perturbations on all residues. DCI 
enables us to identify DARC spot residues, which are more sensitive to perturbations 
exerted on residues critical for function. This index can be utilized to identify the residues 
involved in allosteric regulation. It is expressed as 
 R =
∑ ∆2 2  ,z¡¢£¤¥¦∑ |∆|26 ,`  
 
(4.4) 
Where ∆ is the response fluctuation profile of residue i upon perturbation of residue 
j. The numerator is the average mean square fluctuation response obtained over the 
perturbation of the functionally critical residues Nfunctional and the denominator is the 
average mean square fluctuation response over all residues. As discussed below, the DFI 
and DCI profiles can also be computed using the covariance matrix obtained from 
Molecular Dynamics simulations rather than the inverse Hessian of the elastic network 
model.  
4.4.4 Molecular Dynamics Simulations 
 Molecular Dynamics (MD) simulations were performed using the AMBER 14 
MD package (Pearlman et al., 1995).  Simulations were run using the Amber14SB 
forcefield. The TIP3P (Sun and Kollman, 1995) water model was used for solvation. The 
pmemd.cuda (Salomon-Ferrer et al., 2013) executable of the AMBER14 package was 
used for GPU acceleration. All simulations were run for 50ns. 
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 To obtain dynamics for each variant, each trajectory was divided into 5ns 
windows. The covariance matrix G for each window was extracted, instead of the inverse 
hessian in the ENM (as in Equation 1), and used to calculate the corresponding DFI and 
DCI profiles as 
 ?∆D72-6 = ?D72-72?∆D72-6 
 
(4.5) 
The DFI and DCI profiles calculated from the last four windows (the final 20ns) were 
averaged to calculate an average DFI and DCI profile. We further investigated the change 
in dynamics upon mutation compared to the wild type structure using ΔDFI and ΔDCI. 
The delta-DFI (ΔDFI) profile was calculated as 
 ∆{ = {§¨©¤¨© − {ª¢{ª¢  
 
(4.6) 
Where DFIdisease is the dynamics profile for the mutated protein structure and DFIwt is the 
dynamics profile for the wild type structure. Similarly, the delta-DCI (ΔDCI) profile was 
calculated as 
 ∆R = R§¨©¤¨© − Rª¢Rª¢  
 
(4.7) 
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CHAPTER 5 
5 ESTIMATING DYNAMICS FROM PROTEIN SEQUENCES 
 
 We describe a novel approach that estimates the dynamics profile of a protein 
from its amino acid sequence. This de novo approach leverages the evolutionary principle 
of coevolution and the Gaussian network model (GNM). We demonstrate that our 
sequence-based GNM approach produces values in good agreement with crystallographic 
B-factors as well as theoretical values predicted from the original GNM that uses the 
structure with a distance cutoff. Remarkably, the results also suggest the ability of our 
sequence-based approach to classify the phenotypes of genomic variants across the 
proteome. 
5.1 Introduction 
 The advent of high-throughput genomic sequencing has led to a burgeoning of 
sequences, providing an unprecedented amount of data for genomic analysis. 
Furthermore, this has also driven the rapid classification of novel genetic variations 
through genome-wide association studies (M. J. Li et al., 2012; Xie et al., 2014). Genetic 
variations usually manifest as non-synonymous single nucleotide variants (nSNVs) that 
can severely impact protein function and lead to disease. Evolutionary approaches based 
on positional amino acid conservation are the most common way to diagnose nSNVs. 
Protein dynamics can also be used to elucidate the functional impact of nSNVs and 
mechanisms of disease, and some recent studies have evinced that a site-specific 
conformational dynamics was capable of diagnosing nSNVs irrespective of evolutionary 
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conservation (Nevin Gerek et al., 2013; Butler et al., 2015; Kumar, Butler, et al., 2015). 
This was the first implementation of site-specific conformational dynamics into proeome-
wide analysis to predict the functional impacts of nSNVs. Although the importance of 
protein dynamics in genetic variation analysis is undeniable, the 3D structure from the 
Protein Data Bank (Berman et al., 2000) is still required to calculate protein dynamics. 
This drastically limits the range of applicability in genomic analysis, since there are 
exponentially more sequences than experimental structures.   
 Recently, coevolution has become a popularized tool for its ability to predict 
structural contacts of 3D structures from sequence information (Marks et al., 2011; Hopf 
et al., 2014; Morcos et al., 2011; Marks et al., 2012; Hopf et al., 2012). Coevolving 
residues are inferred from a multiple sequence alignment (MSA) of a given protein 
family, whereby if two given amino acids exhibit concordant patterns of evolution 
throughout the MSA then they are assumed to be close in spatial proximity in the folded 
3D structure. For a given protein family, the conservation of certain mutations over 
different homologs serves as a restraint on function, which is why there can be many 
different sequences in a family that lead to a protein with the same function. Thus, this 
evolutionary principle allows us to leverage sequence information to describe protein 
topology, making de novo structure predictions possible (Marks et al., 2012). It has been 
reported that only one correct contact for every 12 residues in a protein is necessary for 
accurate topology-level modeling (Kim et al., 2014). A study by Marks et al. used 
coevolution to predict 15 structures from different fold classes (ranging between 50-260 
residues), including a G-protein coupled receptor (a class of membrane proteins that are 
notoriously difficult to predict) with minimal RMSD error between 2.7–4.8 Å relative to 
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the known structure (Marks et al., 2011). In addition to structure prediction, coevolution 
analysis has also been used to identify critical interactions between protein complexes 
(Hopf et al., 2014) important functional sites (Marks et al., 2012) and allosteric response 
(Smock et al., 2010). The use coevolution in structure prediction is largely possible for 
two reasons. First, the amount of sequence data for different protein families is sufficient 
to be leveraged by this technique to make predictions. Second, the methods for inferring 
coevolving residues from an MSA are becoming increasingly superior and accurate (de 
Juan et al., 2013). 
 Inferring evolutionary couplings from an MSA are based on three primary 
approaches: maximum entropy models, Bayesian network models, and machine learning. 
A problem in coevolution analysis is that many residue pairs predicted to be correlated in 
are not close in spatial proximity, and thus are not true structural contacts. This is mainly 
due to transitive correlations in the MSA of the protein family that leads statistical 
“noise” and incorrectly predicted couplings (indirect couplings). For instance, if residue 
B is correlated with A and C, then we may find that A and C are correlated even though 
they may not be structural contacts–A and C is a transitive correlation. Thus, the 
challenge is discerning coevolving pairs that are true spatial contacts (direct couplings) 
from the background of noise created by weakly correlated mutations due to transitive 
effects that are not true spatial contacts (indirect couplings). Mutual information (MI) is a 
statistical model that has been used to infer coevolving residue pairs in an MSA 
(Gouveia-Oliveira and Pedersen, 2007; Dunn et al., 2008). It considers the frequency of 
occurrence of amino acids in each column i,j in a given MSA and uses Shannon 
information entropy to determine which pairs are most likely correlated. For a given 
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column i in an MSA, I«K is the frequency count of a particular amino acid, A.  
Likewise, for a pair of columns i,j in an MSA, I«, UK is the frequency of amino acids, 
A and B, appearing simultaneously in the two columns. Then the MI score indicates the 
degree of correlation between two residues i,j (columns in the MSA) as   =
∑ I«, UK ln z­I],AKzI]Kz­IAK],A  (Cover and Thomas, 2006). The MI method is a local measure 
of correlations (i.e., it only considers the correlation of one residue pair at a time), thus it 
is inherently limited by the transitivity effect and cannot discern direct from indirect 
couplings (Marks et al., 2011). For this reason, MI is not sufficient to describe spatial 
proximity of contacts in the 3D structure. Direct coupling analysis (DCA) is a global 
approach that can disentangle direct couplings from indirect couplings and captures true 
spatial contacts (Morcos et al., 2011). This statistical approach is based on the maximum 
entropy method, which gives the maximal probability function of residue pair 
correlations over the whole sequence of length L as ®I«6, … , «¯K =
6° expP∑ <I«, UK + ∑ ℎI«Kµ Q, with Z being a normalizing factor, <I«, UK the 
pairwise couplings, and ℎI«K a local bias field. This formulation is analogous to the 
Ising model describing neighboring spin interactions in ferromagnetic materials. The 
pairwise couplings <I«, UK and ℎI«K are solved by various numerical technqies (e.g., 
mean field approximation). Then the strength of coupling between residue pairs is given 
by their direct information (DI) score as  = ∑ ®¶·I«, UK ln X ¸­¹ºI],AKzI]Kz­I]K\],A , where 
®¶·I«, UK is the effective pair probability and I«K and IUK are the single residue 
frequencies. A notable difference between DI and MI is that the local frequency count 
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I«, UK in MI is replaced by the pair probability ®¶·I«, UK which captures global 
coupling effects over all pairs i,j in the sequence. Thus, the DCA approach eliminates the 
problem of transitive correlations that occurs with MI, and can be surmised as a “noise 
filter” that can identify the most causative correlations that represent spatial contacts in 
the tertiary structure. 
 Several web servers have been developed that use DI in the DCA framework such 
as EVfold (Marks et al., 2011) and PSICOV (Jones et al., 2012). Another approach uses 
pseudo-likelihood maximization (PLM) instead of DI to infer direct couplings (Ekeberg 
et al., 2013), which is implemented in the servers GREMLIN (Kamisetty et al., 2013) 
and CCMpred (Seemayer et al., 2014). Bayesian network models can also be used to 
predict evolutionary couplings and improve contact map prediction (Burger and Van 
Nimwegen, 2010). Regardless of the method, the accuracy of detecting coevolving 
residues that correspond to structural contacts is contingent on the number of sequence 
homologs in the MSA (a sufficient number is on the order of 5 ×[length of protein 
sequence]). Most of the current methods use only the sequence homologs of the protein 
family of the target sequence, which is often less than the optimal number of homologs to 
produce accurate statistical inferences. Dunn et al. previously addressed this concern by 
integrating multiple protein families that were orthologs (i.e., they share similar 
phylogeny and retain similar functions) to increase the number of homologs (Dunn et al., 
2008). A recent approach, RaptorX, leveraged this joint family approach and used a 
supervised machine learning method along with coevolution information to infer 3D 
contacts, and has proven to obtain higher accuracy than the other methods (Ma et al., 
2015; Wang et al., 2016). 
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 We propose a novel sequence-based approach to estimate the dynamics profile of 
a protein, with no a priori knowledge of its 3D structure. This de novo approach based on 
a Gaussian network model (GNM) enables the prediction of the magnitude of mean-
square fluctuations of residues, which are proportional to the B-factors determined by X-
ray crystallography experiments (as described in detail in Chapter 2). However, instead of 
using a cutoff distance to determine 3D contacts as in the original GNM, we use 
coevolving residues (evolutionary couplings (ECs)) in our model. We show that the 
theoretical predictions from our sequence GNM are in good agreement with experimental 
crystallographic B-factors as well as values obtained from the original GNM. We also 
extend this analysis to determine the capacity of our model to assess the functional 
impact of nSNVs. We will demonstrate that the dynamics as predicted from the sequence 
GNM can classify disease and benign nSNVs across the proteome.  
5.2 Methods 
5.2.1 Dataset 
 A curated set of 139 structures was procured from a previous dataset used by 
Butler et al. in a proteomic study of enzymes (presented in Chapter 4). These structures 
were selected for several reasons. First, they have high query coverage (>80%) and 
sequence identity (>80%) as found from a BLAST search, and the structures had already 
been modeled using the Modeller software package (Eswar et al., 2006) to account for 
any missing residues. Second, genetic variants were previously mapped onto these 
structures, such that the positions containing known nSNVs were already determined, 
enabling us to easily compare our results using sequence coevolution with the genetic 
variation data. A total of 738 genetic variants were obtained from the HumVar database 
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(Adzhubei et al., 2010), which was comprised of 436 disease and 302 neutral nSNVs. 
Finally, the structures were either monomers or the single-chain unit of a multimer with 
<600 residues, allowing for tractable calculations of residue coevolution using the 
RaptorX web server. A table summarizing the dataset is presented in Table 1. 
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PDB Length Resolution 
(Å) 
Biological Unit Disease 
nSNVs 
Neutral 
nSNVs 
12ca 255 2.4 MONOMERIC 2 1 0.489 0.605 0.479 
12gs 208 2.1 DIMERIC  1 0.332 0.664 0.374 
1bix 275 2.2 MONOMERIC  1 0.247 0.731 0.420 
1c7p 133 2.4 MONOMERIC 1 1 0.671 0.696 0.715 
1crm 256 2 MONOMERIC 3 16 0.530 0.640 0.487 
1d4a 273 1.7 DIMERIC  2 0.432 0.673 0.191 
1d5r 307 2.1 MONOMERIC 8  0.500 0.621 0.469 
1d6n 214 2.7 DIMERIC 12 7 0.085 0.359 0.283 
1dhf 182 2.3 DIMERIC 2  0.616 0.649 0.750 
1eai 240 2.4 TETRAMERIC  1 0.636 0.770 0.734 
1ege 387 2.75 TETRAMERIC 3 4 0.244 0.248 0.765 
1eh5 279 2.5 MONOMERIC 5  0.464 0.646 0.552 
1f7z 213 1.55 DIMERIC 2  0.678 0.551 0.820 
1fb5 320 3.5 TRIMERIC 37 3 0.349 0.738 0.523 
1fj2 229 1.5 MONOMERIC  1 0.827 0.560 0.573 
1fro 176 2.2 DIMERIC  1 0.566 0.404 0.921 
1gv7 123 2.1 MONOMERIC 5 1 0.337 0.569 0.692 
1h0n 288 2.4 DIMERIC 2  0.462 0.561 0.574 
1hdr 236 2.5 DIMERIC 5 2 0.352 0.622 0.561 
1hne 218 1.84 HEXAMERIC 11  0.660 0.779 0.767 
1hrk 359 2 DIMERIC 2  0.411 0.581 0.530 
1hrn 335 1.8 DIMERIC 2  0.397 0.443 0.691 
1hyo 416 1.3 DIMERIC 6  0.636 0.586 0.467 
1i0z 332 2.1 TETRAMERIC  9 0.729 0.611 0.721 
1iat 556 1.62 DIMERIC 5 3 0.624 0.485 0.556 
1ib0 272 2.3 MONOMERIC 7 2 0.559 0.644 0.704 
1ihg 364 1.8 MONOMERIC  2 0.255 0.399 0.704 
1is7 194 2.8 EICOSAMERIC 7  0.541 0.534 0.719 
1itq 369 2.3 DIMERIC  1 0.517 0.729 0.811 
1ivh 387 2.6 TETRAMERIC 1  0.366 0.426 0.739 
1j9w 257 2.6 MONOMERIC  3 0.298 0.522 0.584 
Table 1: Proteins used to compute theoretical B-factors based on sequence GNM 
and structural GNM approaches.  
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1jph 357 2.1 DIMERIC 7 2 0.532 0.556 0.781 
1jqi 384 2.25 TETRAMERIC  1 0.561 0.573 0.774 
1jxv 149 2.2 HEXAMERIC 1 2 0.201 0.407 0.809 
1k62 450 2.65 TETRAMERIC 1  0.549 0.573 0.696 
1l1f 496 2.7 HEXAMERIC 3 16 0.420 0.267 0.799 
1li4 430 2.01 TETRAMERIC  1 0.240 0.306 0.657 
1ls6 288 1.9 MONOMERIC  2 0.391 0.637 0.296 
1m9n 590 1.93 DIMERIC 1 1 0.402 0.233 0.571 
1mc5 373 2.6 DIMERIC  1 0.335 0.364 0.625 
1mir 313 2.8 DIMERIC  1 0.552 0.704 0.638 
1og2 462 2.6 MONOMERIC  1 0.549 0.594 0.704 
1ogs 497 2 MONOMERIC 53 1 0.362 0.688 0.576 
1ohv 461 2.3 DIMERIC 1 10 0.435 0.518 0.265 
1ore 179 2.1 DIMERIC 1  0.657 0.744 0.794 
1pf7 288 2.6 TRIMERIC 2  0.490 0.576 0.721 
1q6x 600 2.5 MONOMERIC 1 3 0.515 0.684 0.673 
1qo5 360 2.5 TETRAMERIC  7 0.582 0.445 0.319 
1r46 390 3.25 DIMERIC 23  0.490 0.554 0.774 
1rx0 384 1.77 TETRAMERIC 2  0.415 0.497 0.692 
1ry0 319 1.69 MONOMERIC  1 0.607 0.698 0.400 
1s8o 545 2.6 DIMERIC  1 0.439 0.641 0.638 
1sir 390 2.6 TETRAMERIC 13 4 0.311 0.363 0.684 
1spj 236 1.7 MONOMERIC  1 0.767 0.826 0.809 
1sw0 247 1.71 DIMERIC 2 2 0.442 0.303 0.695 
1t1u 597 1.55 MONOMERIC 10  0.478 0.731 0.670 
1tdi 218 2.4 DIMERIC  1 0.743 0.596 0.446 
1u7t 255 2 TETRAMERIC 1  0.374 0.411 0.759 
1umk 271 1.75 MONOMERIC 1 1 0.778 0.788 0.682 
1v9e 259 1.95 MONOMERIC 3  0.620 0.733 0.644 
1vrp 370 2.1 DIMERIC  1 0.401 0.550 0.804 
1waw 366 1.75 DIMERIC  2 0.615 0.671 0.785 
1wsr 371 2 DIMERIC 2  0.622 0.655 0.760 
1wva 309 1.94 TRIMERIC 1  0.305 0.365 0.808 
1xfb 342 3 TETRAMERIC 1 4 0.680 0.566 0.778 
1yuw 554 2.6 MONOMERIC  3 0.453 0.637 0.722 
1z10 465 1.9 MONOMERIC  8 0.418 0.678 0.698 
1zmc 472 2.53 DIMERIC 1 18 0.436 0.528 0.728 
2aaq 461 2.6 DIMERIC  1 0.290 0.415 0.596 
2ag5 256 1.84 TETRAMERIC  1 0.568 0.459 0.769 
2bh9 489 2.5 DIMERIC 34  0.403 0.422 0.811 
2boa 404 2.2 MONOMERIC  1 0.677 0.382 0.388 
2c9y 218 2.1 MONOMERIC  1 0.265 0.343 0.788 
2cga 245 1.8 DIMERIC  1 0.167 0.636 0.337 
2esl 181 1.9 DIMERIC  1 0.543 0.616 0.775 
2etl 223 2.4 MONOMERIC 1  0.435 0.596 0.586 
2f3b 326 1.8 TETRAMERIC  1 0.680 0.552 0.708 
2fpg 305 2.96 DIMERIC 1  0.254 0.498 0.402 
2fvl 323 2.4 MONOMERIC  1 0.288 0.425 0.417 
2gao 186 2 DIMERIC 1  0.160 0.677 0.472 
2h57 165 2 MONOMERIC 4 10 0.433 0.621 0.739 
2he3 185 2.1 TETRAMERIC  1 -0.060 0.180 0.533 
2hgs 472 2.1 DIMERIC 1 4 0.600 0.600 0.627 
2i3y 188 2 TETRAMERIC  1 0.227 0.413 0.469 
2ib7 391 2.05 TETRAMERIC 1 5 0.540 0.709 0.768 
2iw2 478 1.82 DIMERIC 3  0.388 0.586 0.445 
2j0f 446 2.31 DIMERIC 2  0.148 0.464 0.418 
2j6l 497 1.3 TETRAMERIC 1 1 0.614 0.365 0.325 
2jao 196 2 DIMERIC  1 0.833 0.625 0.577 
2jbm 290 2 HEXAMERIC  1 0.500 0.204 0.458 
2jif 381 2 TETRAMERIC  1 0.482 0.398 0.838 
2o48 331 2.59 DIMERIC  2 0.645 0.537 0.651 
2ozl 362 1.9 TETRAMERIC 6 8 0.454 0.350 0.604 
2p02 380 1.21 DIMERIC 5  0.641 0.705 0.600 
2p9q 416 2.7 MONOMERIC 7 17 0.391 0.490 0.704 
2pla 343 2.51 DIMERIC 2 6 0.140 0.323 0.675 
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2vcy 332 2.41 DIMERIC  1 0.488 0.636 0.819 
2w2j 268 1.6 MONOMERIC  4 0.810 0.746 0.736 
2w8n 480 2 TETRAMERIC 2 1 0.234 0.157 0.519 
2wd9 533 2.6 MONOMERIC  1 0.105 0.249 0.416 
2wid 527 2.3 MONOMERIC 11 9 0.518 0.704 0.771 
2wkl 497 2.7 MONOMERIC 3 3 0.317 0.655 0.530 
2xe6 413 1.74 MONOMERIC 1 8 0.568 0.567 0.781 
3bur 325 1.62 MONOMERIC 2  0.375 0.751 0.393 
3cmq 405 2.2 MONOMERIC  2 0.496 0.631 0.513 
3ecr 339 2.18 MONOMERIC 1  0.552 0.656 0.572 
3fw1 228 1.75 DIMERIC  2 0.385 0.580 0.596 
3gro 277 2.53 DIMERIC 1  0.472 0.618 0.521 
3h53 387 2.01 DIMERIC 1  0.459 0.557 0.753 
3hlm 401 2.5 DIMERIC  1 0.369 0.265 0.948 
3i2b 138 2.3 TRIMERIC 9  0.410 0.480 0.643 
3iar 360 1.52 MONOMERIC 6 1 0.384 0.552 0.788 
3ibd 465 2 MONOMERIC  1 0.419 0.519 0.663 
3k9v 464 2.5 MONOMERIC 4  0.426 0.490 0.692 
3o9m 531 2.98 TETRAMERIC 6 4 0.454 0.630 0.777 
3pm0 463 2.7 MONOMERIC 2  0.528 0.509 0.643 
3qic 453 2.2 MONOMERIC 1 7 0.107 0.676 0.415 
3ruk 473 2.6 MONOMERIC 2 16 0.511 0.329 0.383 
3sza 447 1.48 DIMERIC  2 0.627 0.795 0.790 
3t1g 349 2.35 MONOMERIC 12  0.658 0.786 0.753 
3u2o 366 2.18 MONOMERIC 1  0.567 0.553 0.507 
3v9g 541 2.5 DIMERIC  1 0.414 0.443 0.796 
3vn9 291 2.6 MONOMERIC  3 0.580 0.705 0.669 
4ah6 589 3.7 DIMERIC 2  0.269 0.420 0.680 
4aj4 331 1.9 TETRAMERIC  1 0.560 0.428 0.878 
4ald 363 2.8 TETRAMERIC 1 1 0.745 0.500 0.404 
4aoh 123 1.04 MONOMERIC 10  0.581 0.616 0.729 
4awn 260 1.95 MONOMERIC  2 0.590 0.739 0.743 
4b3e 153 2.15 DIMERIC 24  0.762 0.471 0.484 
4fdi 494 2.2 DIMERIC 3  0.471 0.715 0.371 
4g1c 267 1.94 DIMERIC  1 0.699 0.526 0.542 
4gab 316 1.6 MONOMERIC  1 0.374 0.707 0.342 
4h2i 524 2 DIMERIC  1 0.429 0.625 0.736 
4hva 238 2.07 TETRAMERIC  1 0.631 0.665 0.735 
5pnt 157 2.2 MONOMERIC  1 0.775 0.684 0.747 
7pck 314 3.2 TETRAMERIC 2  0.450 0.548 0.713 
1dch 104 3 TETRAMERIC 1  – – 0.477 
1pbh 317 3.2 MONOMERIC  1 – – 0.656 
1xwn 174 – MONOMERIC  1 – – 0.932 
 
5.2.2 Obtaining Coevolved Residues  
 The amino acid sequence from each of the 139 structures was used as input for 
the evolutionary coupling (EC) analysis. The choice of taking the amino acid sequence 
from the structure was done so that the predicted EC contacts could be compared directly 
to the experimentally observed structure contacts as verification that the model was 
producing realistic contact maps. Moreover, the theoretical B-factors predicted by our 
sequence-based model could be directly compared to the experimental B-factors for each 
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protein. If the structure was unknown, however, sequence databases (e.g. UniProt, 
PFAM, etc.) as discussed in Chapter 1 could be used. The PDB sequences were given to 
the RaptorX web server (Wang et al., 2016; Ma et al., 2015), which computed the 
relative probability of each residue pair i, j of being in 3D contact based on their 
coevolution strength. In order to ensure consistency between different proteins of varying 
lengths, we converted the raw scores into percentile ranks. We then used a threshold 
value, taking only the top scoring evolutionary couplings (i.e., the strongest couplings are 
more likely to be in spatial contact). An optimized threshold value was systematically 
evaluated and is discussed in the Results (Section 5.3). 
5.2.3 Sequence-based GNM Model  
 The Gaussian network model (GNM) is an isotropic approach based on the 
contact topology of a crystal protein structure to obtain the equilibrium fluctuations of 
residues due to thermal motion. It uses a specified cutoff distance to define interacting 
pairs that are connected by springs with a single-parameter harmonic potential (detailed 
review in Chapter 2). In this structure-based GNM, the interacting residue pairs within 
the cutoff range are represented as contacts in the Kirchhoff (connectivity matrix). 
 In the proposed sequence-based GNM approach we will instead use coevolving 
residue pairs (evolutionary couplings) as contacts in the Kirchhoff. In this way, the 3D 
structure is no longer a prerequisite to form a GNM. To construct the Kirchhoff, a 
threshold is defined where any evolutionary coupling scores above that threshold are 
sufficiently coupled such that they are spatially close in 3D structure. If a given 
evolutionary coupling pair meets the threshold criteria, it is assigned a value in the 
Kirchhoff for non-bonded contacts of –1 multiplied by its evolutionary coupling score 
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(i.e., –1×ECscore). This will permit that the strength of each connection will attenuate 
proportionally to the evolutionary coupling strength. The Kirchhoff can be decomposed 
into the individual contributions from the bonded contacts representing the chain 
connectivity (Rouse chain) and that from the non-bonded contacts (Bahar et al., 1997). In 
the sequence GNM the contribution of non-bonded contacts to the Kirchhoff is 
constructed according to 
 Γ	 =  
!−1 - EC½¾¿ÀÁ,								$ % &	   evolutionary	coupling								0,															i % &									no	coupling																								− ) Γ,+ ,									$ = &																																																												
 (5.1) 
Similarly, the chain connectivity (Rouse chain) matrix was constructed such that every 
residue pair i, i ± 1 to i, i ± 3 are in contact as 
 Γ	 =
 
! −1,							$ % &				and				) $, $ ± @¯|N6,,7 	0	,									$ % &					else																															– ) Γ,+ ,				$ = &																																													
 (5.2) 
Then the overall Kirchhoff is the combination of the two contributions (Γ = Γ + Γ). 
The vibrational dynamics due to thermal fluctuations can then be evaluated in the same 
way as the original GNM by inverting the Kirchhoff matrix. The magnitude of mean-
square fluctuations is then written in terms of the inverse Kirchhoff as 
 〈IΔK〉 ≅ ?ΓL6D (5.3) 
This is proportional to the Debye-Waller temperature factors or B-factors, which describe 
the attenuation of X-ray scattering due to the thermal motions of atoms (U =
8W〈IΔK〉 3⁄ ). Here there is no single-parameter force constant as in the structure 
GNM (Tirion, 1996), and the pair-wise interactions are simply the strength of the 
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evolutionary couplings as given by their ranked scores. The theoretical predictions of our 
sequence GNM can be compared to the predictions of the original structural GNM as  
well as observed crystallographic B-factors. A general workflow of our method is 
presented as a flow diagram in Figure 5.1.   
5.3  Results and Discussion 
5.3.1 Optimizing Threshold Value for EC Scores 
 Not all of the predicted EC contacts are true 3D contacts, largely due to noisy 
artifacts in the MSA such as the transitivity of correlations and phylogeny. With this in 
mind, we decided to accept only the top scoring contact scores predicted by RaptorX. To  
 
Figure 5.1: A workflow of our method to use predicted evolutionary couplings to 
determine protein dynamics and assess the functional impact of nSNVs. The 
initial input is an amino acid sequence, which is given to the RaptorX webserver 
to predict evolutionary coupling pairs that are used as contacts in the GNM 
model. Using a GNM, we compute the dynamics profile of each protein, which 
can give insight into the functional impact of nSNVs. This was done for a 
curated set of 139 structures. 
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 ensure consistency when analyzing different proteins with varying lengths, we converted 
the raw scores into a percentile rank. We then computed the sequence GNM for all 139 
structures using a constant threshold value, and measured the correlation between the B-
factors predicted by our sequence GNM to the original GNM. To determine the optimal 
threshold value, this procedure was done 8 times using a range of threshold values from 
0.92 to 0.99. A threshold value ≤0.92 yields superfluous contacts leading to a noisy 
contact map, and thus, a lower overall correlation (Figure 5.2). Conversely, a threshold 
value ≥0.99 gives a deficient number of contacts, which yields an excessively sparse 
contact map and a lower overall correlation. As Figure 5.2 shows, a threshold value of 
0.98 produced the best overall correlation with the original GNM and, thus, was taken to 
be the optimal threshold value used in the analysis. 
 
Figure 5.2: A boxplot comparing the correlations of predicted B-factors by the 
sequence GNM with that of the structural GNM for all 139 structures using a 
constant threshold for EC contacts. In order to determine the optimal threshold 
value the GNM analysis was conducted 8 times using a constant threshold 
(between 0.92 and 0.99) each time. The best correlations were produced when the 
constant threshold value of 0.98 was used. In this context the average correlation 
coefficient was 0.63 for all 139 cases. 
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5.3.2 B-factor Correlations: Sequence, Structure, and Experimental  
 We compared our theoretical predictions using the sequence GNM with the 
original structural GNM and crystallographic B-factors. Unreliable B-factors are common 
for many PDB structures. For instance, poor B-factors could be due to low-resolution X- 
ray diffraction data, the fact that crystal contacts are formed during the experiments that 
impede motion and do not accurately reflect the protein in the cellular environment, or 
the temperature of the experiment was not at physiological temperature, which will affect 
the thermal motions. Thus, for the experimental comparison we extracted a subset of 39 
structures that had a resolution better than 2.0 Å to obtain more realistic crystallographic 
B-factors. The same cutoff of 2.0 Å was used by Kundu et al. to compare GNM predicted 
B-factors with those determined by crystallography (Kundu et al., 2002). For all 39 
 
Figure 5.3: Comparing the distribution of correlation coefficients of experimental B-
factors with the theoretical B-factors from the sequence GNM and the structure 
GNM. (A) A boxplot showing the correlation of predicted B-factors by the sequence 
GNM with experimentally observed B-factors (blue) in comparison to that of the 
structural GNM (orange) for a subset of 39 structures with resolution better than 2.0 
Å. (B) A distribution plot of the same correlations binned in into 10 bins with sizes 
of 0.1. A student t-test revealed no significant difference between the two 
distributions (p=0.05508) indicating that the sequence GNM is producing 
competitive results compared to the original structural GNM. The mean correlation 
of the sequence GNM is 0.53 while that of the structural GNM is 0.58. 
  
102
structures, the sequence GNM and structure GNM was computed and their estimated B-
factors were compared with the observed B-factors, yielding a correlation for each 
protein. As shown in Figure 5.3A, the boxplot distributions of correlations are similar 
between the sequence and structure GNM (p = 0.055 in a student t-test), with the 
structure GNM appearing to be slightly superior to the sequence GNM. Figure 5.3B 
shows the same distribution separated into 10 individual bins of size 0.1. The overall 
shapes of the two distributions are similar, except for the exaggerated peak of the 
sequence GNM at 0.4. Interestingly, the sequence GNM has a higher count of 
correlations between 0.8–0.9 compared to structure GNM by a factor of 2. It should also 
be noted that for these cases where sequence GNM had low correlations, the EC 
threshold could be adjusted to yield much higher correlations. If this were done on a case-
by-case basis, the overall correlation distribution would be almost identical. Using the 
threshold as an adjustable parameter to tune the correlation coefficient such that it is 
maximal is entirely possible. For instance, we could compute the sequence GNM using 5 
different threshold values and accept the value that yields the best correlation with 
experiment. Although this technique would likely produce as good or better results as the 
structure GNM, the procedure would no longer be de novo since it would rely on 
knowledge of the structure. The mean correlation coefficient for the sequence GNM was 
0.53 while the mean correlation coefficient for the structure GNM was 0.58. This is 
consistent with the findings of Kundu et al. that computed the GNM for 113 high-
resolution structures (resolution <2.0 Å) in which the mean correlation coefficient with 
observed B-factors was also 0.59 (Kundu et al., 2002). The fact that the sequence GNM 
produces comparable correlation coefficients to the structure GNM, and is superior in the 
  
103
range of coefficients between 0.8–0.9, is an impressive result, particularly in that it is a 
rather crude model to approximate protein dynamics using only a protein sequence.  
 Even when using high-resolution X-ray structures, there is still some uncertainty 
about the realistic nature of crystallographic B-factors. For this reason, a more plausible 
way to determine the efficacy of the sequence GNM is to compare it directly with the 
structure GNM. The structure GNM is a powerful tool to describe thermal fluctuations in  
a protein, and in many cases it performs as good or better than the ANM or MD (Doruker 
et al., 2000; Kundu et al., 2002). We systematically evaluated the sequence and structure 
GNM for the entire set of 139 structures and obtained the correlation coefficients for each 
protein (Figure 5.4). The average correlation between the two models is 0.63. As seen in 
Figure 5.4, the distribution of correlation coefficients increases monotonically until 0.8, 
and then subsequently decreases. Interestingly, there are still an appreciable number of 
exceedingly high correlations from 0.8 to 1.0. A distinguishing feature of the distribution 
 
Figure 5.4: The distribution of correlation coefficients between the sequence and 
structure GNM predicted mean-square fluctuations as computed from 139 structures 
(listed in table 5.1). The threshold for evolutionary couplings was 0.98 and the 
average correlation coefficient was 0.63. 
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is the pronounced peak in the bin from 0.7 to 0.8. The saturation of high correlations 
between 0.7–0.8 provides evidence that the sequence GNM is clearly capturing protein 
dynamics. This is indicative of the efficacy of using evolutionary couplings as contacts in 
the GNM in place of the structure contacts.  
 We also considered two high-resolution proteins (<2.0 Å), 1UMK and 1SPJ, to 
examine their B-factor profiles and predicted contact maps. Coevolution analysis using 
 
Figure 5.5: A plot of theoretical B-factors as calculated by our sequence GNM 
(blue), the original GNM (orange), and observed experimental B-factors (black) for 
two proteins, Human Erythrocyte NADH-cytochrome b5 Reductase (PDB code: 
1UMK) and Human Kallikrein 1 (PDB code: 1SPJ). The respective contact maps are 
shown to the right. These two proteins 1UMK and 1SPJ are adequate for comparing 
experimental B-factors since they have resolution of 1.75 Å and 1.7 Å respectively, 
thus their B-factors are likely more reliable. In both cases our sequence GNM 
produced exceptional correlations with both experimental and structural GNM B-
factors. For 1UMK the sequence GNM produced a correlation of 0.78 with 
experiment, and 0.68 with the structural GNM. For 1SPJ the sequence GNM 
produced a correlation of 0.77 with experiment, and 0.81 with the structural GNM. 
Moreover their contact maps reveal the predicted contacts between the sequence and 
structural GNM approaches are remarkably similar.  
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DCA has been shown to recapitulate accurate structural contact maps for many proteins 
(Morcos et al., 2011; Marks et al., 2012, 2011). As expected, in both cases the contact 
maps between sequence and structure GNM were remarkably similar (Figure 5.5). In 
looking at their B-factor profiles, both sequence and structure GNM exhibit good 
agreement with observed B-factors, capturing each of the peaks. The correlation between 
the sequence GNM and observed B-factors is 0.78 for 1UMK and 0.77 for 1SPJ, whereas 
the correlation between the structure GNM and observed B-factors is 0.79 for 1UMK and 
0.83 for 1SPJ. We surmise that the sequence GNM produces exceptional correlations 
with crystallographic B-factors that are very close to those produced by the structure 
GNM. Moreover, both theoretical B-factor profiles identified the catalytic sites on these 
proteins (i.e., low mobility sites).  
 As a further test to the efficacy of the sequence GNM, we superimposed the 
predicted B-factors on the structures of three diverse proteins–2JAO, 1FJ2, and 1UMK–
to visually contrast the predicted B-factors with that of experiment. Figure 5.6 shows 
each protein color-coded according to their B-factor profile on a spectrum of blue–white–
red, where blue represents the lowest B-factors (less mobility) and red represents the 
highest B-factors (more mobility). The left panel shows the experimental B-factors for 
each protein, while the right panel shows the theoretical values predicted by the sequence 
GNM. We investigated whether secondary structure was a factor in how the B-factors 
were distributed across the protein, and if certain secondary structure domains would 
exhibit less agreement with experiment. In this context, the proteins were selected so that 
they had a variety of secondary structure components–2JAO contains primarily alpha 
helices, 1UMK is mainly composed of beta-sheets, and 1F2J is a combination of alpha  
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 helices and beta-sheets. For 2JAO, the exterior helices that are flexible (red) in the 
observed structure are all reproduced in the predicted structure. The one highly rigid 
(blue) helix in the observed structure was more flexible in the predicted structure, but was 
 
Figure 5.6: The observed crystallographic B-factors (left) and the predicted B-
factors from the sequence GNM superimposed on the structure. The three proteins 
selected–2JAO, 1F2J, and 1UMK–were high-resolution structures better than 2.0 Å. 
The B-factors are color-coded according to their B-factor profile on a spectrum of 
blue–white–red where blue represents the lowest B-factors (less mobility) and red 
represents the highest B-factors (more mobility). The B-factor scores were 
converted to a percentile rank so that they could be compared across different 
proteins. Each protein was also rotated 180° so that both sides could be visualized 
and compared. Moreover, the proteins were selected so that they had a variety of 
secondary structure components–2JAO contains primarily alpha helices, 1UMK is 
mainly composed of beta-sheets, and 1F2J is a combination of alpha helices and 
beta-sheets.  
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still in overall agreement. 1FJ2 shows a remarkable agreement between observed and 
predicted structures, particularly considering that it is a combination of alpha helix and  
beta-sheet elements. Similarly, 1UMK showed excellent agreement aside from some very 
miniscule differences. Overall, this gives further credence to the efficacy of our sequence 
GNM model, as it is capable of recapitulating crystallographic B-factor profiles for many 
cases.  
5.3.3 Assessing nSNV Phenotypes Using the Sequence GNM 
 Crystallographic B-factors have previously been used to assess the impact of 
nSNVs on protein function (Chasman and Adams, 2001; Adzhubei et al., 2010; Alber et 
al., 1987; Nevin Gerek et al., 2013). A study by Alber et al. found that mutations on 
lysozyme that impaired function exhibited lower than average temperature factors, 
suggesting that rigid sites on the protein are more susceptible to destabilizing nSNVs than 
flexible sites (Alber et al., 1987). Another study also revealed a relationship between 
crystallographic B-factors and the impact of nSNVs on protein function (Chasman and 
Adams, 2001). A commonly used tool to diagnose nSNVs, PolyPhen-2, that uses 
machine learning coupled with evolutionary information and structural information uses 
crystallographic B-factors in their predictions (Adzhubei et al., 2010). In essence, these 
studies indicate that crystallographic B-factors can be used to predict the tolerance of a 
given residue to an nSNV (i.e., whether or not the occurrence of an nSNV would impact 
function).  
 We investigated whether B-factors predicted by the sequence GNM was 
indicative of biological phenotype for nSNVs in the human population. A total of 738 
nSNVs were mapped to the 139 enzymes, in which 436 are associated with disease and 
  
108
302 are neutral. Table 5.1 shows the number of disease and neutral nSNVs that occur on 
each protein. The sequence GNM was computed systematically for all 139 enzymes to 
obtain their dynamics profiles. The theoretical B-factors scores were converted into a 
percentile rank so that the values could be compared across different proteins.  
 We initially looked at two human enzymes, human lysozyme (PDB: 1C7P) and 
human cytochrome reductase (PDB: 1UMK). They were chosen because they were short  
proteins with each containing a disease and neutral nSNV. Human lysozyme is a 
glycoside hydrolase that functions in the immune system by causing damage to cell walls 
of bacteria. Human cytochrome b5 reductase is involved in many oxidation/reduction 
reactions including converting methemoglobin to hemoglobin (Elahian et al., 2012). Each 
structure is color-coded according to its theoretical B-factor profile on a spectrum of 
blue–white–red. Sites that exhibit high mobility (flexible) are red, and sites that have low 
 
Figure 5.7: A ribbon diagram for two human enzymes, human lysozyme (A) and 
cytochrome reductase (B) colored according to their predicted B-factors by the 
sequence GNM. Red indicates high mobility sites, and blue indicates low mobility 
sites. Each protein contains two known nSNVs. I56T and R57Q are disease-
associated, and they occur on low mobility (rigid) sites. Conversely, the neutral 
nSNVs T116S and T70N occur on high mobility sites.  
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mobility (rigid) are blue. Regions that are characterized by low mobility are usually 
important for maintaining stability and function, thus a mutation could act to destabilize 
the protein and impair its function. Figure 5.7A shows the disease mutation I56T 
occurring on a rigid site with a B-factor of 0.0075. The neutral mutation T70N has a B-
factor of 0.96 indicating that it is a highly mobile site. Both I56T and T70N occur on loop 
regions. Although loops are generally more flexible, three alpha helical domains 
encompass the loop containing I56T, which implies that it may be involved in 
interactions that contribute to stabilizing the functional conformation. Thus, the I56T 
mutation may disrupt these critical interactions and impair the enzymatic function. In the 
case of cytochrome reductase (Figure 5.7B), the disease mutation R57Q is also on a rigid 
site with a B-factor of 0.14. Instead of being located near the core, R57Q is highly 
exposed protruding outwardly from a beta-barrel. However, since beta-barrels often 
harbor functional residues, the R57Q mutation may disrupt certain interactions critical for 
modulating function. The neutral mutation T116S is located on a loop and has a B-factor 
of 0.96, indicating that is it has a high mobility. Sites that are highly flexible (e.g., loop 
regions, or superficial sites) are more robust to mutations. Conversely, rigid sites are 
more susceptible to mutations that significantly impact function. For these two cases, the 
theoretical B-factors produced by the sequence GNM convincingly discriminated 
between the disease and neutral nSNVs.  
 The findings based on the two enzymes encouraged us to look at a proteome-wide 
set of 139 enzymes to determine whether the distribution of B-factors for all 436 disease 
and 302 neutral nSNVs was predictive. The B-factor scores were ranked into percentiles 
(%B-factor) and then binned into 5 bins of size 0.2. Then we computed the observed-to-
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expected ratio of B-factors, where the expected values were based on the B-factor 
distribution of all 51,618 sites across all 139 proteins, and the observed values were based 
on the B-factors of the 436 disease sites. The same process was done for the 302 neutral 
nSNVs. Then under the null hypothesis of no effect, the ratio of expected and observed 
sites harboring disease mutations for each %B-factor bin should be close to 1. A strong 
relationship between disease sites and the %B-factor score would reject the null 
hypothesis that disease sites are distributed uniformly between sites with low and high  
mobility. For the 436 disease nSNVs, this null hypothesis was rejected (p <0.001). Figure 
5.8 shows the observed-to-expected ratio plot of disease and neutral nSNVs, which 
indicates that disease nSNVs are overabundant at low %B-factor sites (<0.4) and 
underabundant at high %B-factor sites. Conversely, neutral nSNVs are overabundant at 
high %B-factor sites (>0.6) and underabundant at low %B-factor sites. This strong 
evidence purports that the occurrence of an nSNV on a site with a low B-factor is likely 
damaging, whereas an nSNV on a high B-factor site is likely to be benign. Low B-factors 
 
Figure 5.8:  The relationship of observed-to-expected numbers between 436 disease 
nSNVs (red) and 302 neutral nSNVs (blue) from 139 human enzymes. The %B-
factor scores derived from the sequence GNM are binned into 5 bins of size 0.2. 
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usually signify a residue that is crucial for modulating functional motions (e.g., a hinge) 
and high B-factor sites are more flexible sites such as loops that are more robust to 
mutations. Figure 5.8 reveals the ability of predicted B-factors to discriminate between 
disease and neutral nSNVs using only sequence as input. The distributions in Figure 5.8 
are remarkably similar to an observed-to-expected ratio plot in a previous DFI analysis of 
nSNV phenotype (Nevin Gerek et al., 2013).  
  
  
112
CHAPTER 6 
6 CONCLUSION 
 
6.1 Summary of Current Work 
 This thesis has presented research on a novel method to explore the role of protein 
conformational dynamics in genomic variation. Some recent studies have evinced that 
molecular evolution utilizes dynamics as a means to control protein function (Haliloglu 
and Bahar, 2015; Tawfik and Tokuriki, 2009; Zou et al., 2015; Kim et al., 2015; Glembo 
et al., 2012; Bhabha et al., 2013; Campbell et al., 2016; Nevin Gerek et al., 2013). Over 
the course of evolution, changes in the conformational landscapes of a protein allow for 
development of new functions or optimization of existing functions (e.g., enzyme 
function), which suggests that molecular evolution and protein dynamics are intertwined 
(Campbell et al., 2016). One evolutionary mechanism that induces changes in protein 
dynamics is mutation. With advanced sequencing technologies it is now known that each 
exome contains many thousands of single nucleotide variants (nSNVs) that can be 
harmful to function. Detecting which variants will lead to human disease is of paramount 
importance, and most current methods involve using evolutionary information. The 
evolution-based methods, which depend largely on amino acid conservation, are able to 
diagnose nSNVs for highly conserved positions but often fail to predict disease-
associated nSNVs at less conserved positions or neutral nSNVs at highly conserved 
positions. Efforts to include structural information resulted in only a minimal increase in 
predictive power, principally because of the use of a static structure. We demonstrated 
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the importance of including protein conformational dynamics, which plays a significant 
role in nSNV phenotype.  
 Proteins usually perform their function by forming complexes biomolecules that 
act in conjunction. The interactions between these complexes at protein-protein interfaces 
is very crucial to their ability to function, thus nSNVs that occur at specific interface sites 
are highly susceptible to disease. We used a novel metric called the dynamic flexibility 
index (DFI) that measures the contribution of site-specific conformational dynamics to 
functional importance. It predicts which sites are flexible and which are more rigid (i.e., 
act as hinges). We demonstrated in a proteome-wide analysis using the DFI metric that 
interface sites are less flexible than non-interface sites, and that particularly low 
flexibility sites (low DFI) at interfaces are more likely to harbor disease nSNVs. Indeed, 
we observed that disease nSNVs at interface sites had appreciably low DFI, whereas 
neutral nSNVs had higher DFI. The DFI metric can quantify which sites contribute the 
most to function (i.e., low DFI sites are more susceptible to damaging nSNVs), and it can 
also identify sites that are less important for function (i.e., high DFI sites are more robust 
to damaging nSNVs). Thus, our dynamics-based metric was able to discriminate disease 
and neutral nSNVs at interface sites. Moreover, we observed that accessible surface area 
(ASA), a metric based on static structure commonly used to study nSNV phenotypes, was 
inferior to DFI in discriminating disease and neutral nSNVs. This emphasizes the 
importance of considering protein dynamics in these types of analysis. Finally, we 
showed that even for the regime of fast-evolving amino acid positions, where 
evolutionary methods tend to be inadequate, DFI was still able to discriminate nSNV 
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phenotypes. These findings point toward the potential efficacy of dynamics-based metrics 
like DFI in genomic analysis of nSNVs.  
 The concept of allostery (i.e., action at a distance) has been studied extensively 
recently for its role in protein function regulation and application in drug design. Certain 
sites on a protein are distal to crucial functional sites (e.g., active sites or binding sites) 
but can still have an impact on those sites and, thus, affect the functional activity of the 
protein. We developed a new dynamics-based metric called the dynamic coupling index 
(DCI), which can identify such sites (called DARC spots) that are distal to active sites but 
are dynamically coupled to them. These DARC spots are sites that are not located in 
close proximity to functional sites but are still important for allosteric regulation and 
function of the protein. Through DCI, we analyzed the enzyme GCase, which has over 
200 mutations that lead to Gaucher disease (GD) in humans. The disease associated 
mutations lead to a drastic decrease in catalytic efficiency that disrupts the function of the 
enzyme. Despite the hundred years of research (i.e., since it was discovered in the late 
19th century), GD has neither a cure or an accepted mechanism for the disease 
(Lieberman, 2011; Hruska et al., 2008; Beutler et al., 1993; Lieberman et al., 2007). 
Through DFI we analyzed four common GD mutations that evolutionary-based methods 
usually misdiagnose as neutral. We observed that each mutation leads to a significant loss 
in flexibility at two highly functional catalytic sites and ligand binding recognition sites, 
both responsible for enzymatic function. This loss in flexibility (i.e., rigidification) 
restricts these sites from modifying their structural conformations to attain the required 
orientations for accommodating a substrate for catalytic function, which results in lower 
catalytic efficiency. Moreover, a DCI analysis of the four mutations revealed that each 
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mutation resulted in a global loss in allosteric coupling between remote sites and the 
active sites. The breaking of crucial allosteric regulation networks between remote sites 
and the active sites is catastrophic for enzymatic function. Thus, these findings provide a 
plausible mechanism for GD based on conformational dynamics. In an analysis of all 
other ~200 GD-related mutations, the DCI metric revealed that the majority of all GD 
occur at high DCI sites (i.e., DARC spots). Since this appeared to be a general trend, we 
conducted a proteome-wide analysis of enzymes, in which we demonstrated that disease 
nSNVs were largely located at DARC spots. Thus, the DCI metric is shown to be able to 
identify important sites (DARC spots) that are more susceptible to damaging nSNVs. We 
also showed that DFI and DCI as a combined metric exhibited remarkable predictive 
power for cases where evolutionary metrics were lacking predictive power in nSNV 
phenotypes. This further illustrates the obvious utility of conformational dynamics-based 
metrics (e.g., DFI and DCI) as in silico tools in genomic analysis to systematically 
quantify and assess nSNVs in terms of their disease risk.  
 Investigating protein conformational dynamics is contingent on the knowledge of 
a 3D native structure. While there is a large body of available experimental structures in 
the Protein Data Bank (PDB), there is still a disproportionate amount of readily available 
sequence data compared to known structures. This wealth of data is a result of advanced, 
high-throughput sequencing technologies and is projected to further increase at an 
exponential rate, continuing to outpace the much slower determination of experimental 
structures. Since our overall goal is to integrate conformational dynamics into genomic 
analysis, the inherent limitations of this must be addressed. The ability to obtain site-
specific conformational dynamics is dependent on the known 3D structure. This begs the 
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question: how can protein dynamics be used in genome-wide analysis to predict 
functional impacts of nSNVs? In particular, the evolutionary methods that use sequence 
information are able to predict the consequences of nSNVs where the structure is 
unknown. For this reason, there is a need to be able to obtain protein dynamics by 
leveraging only sequence information, without a priori knowledge of a 3D structure. This 
ability would be a tremendous achievement considering the abundance of sequence data. 
We have developed a novel method to estimate the dynamics profile of a protein, using 
only a sequence as input. The method uses the coevolution of amino acids in an 
alignment of sequences (which tend to be spatially close in the 3D tertiary structure) and 
a simple Gaussian network model (GNM) to obtain dynamics. The original GNM based 
on the 3D structure is well-known for its intrinsic ability to describe residue dynamics 
profiles due to thermal motions in proteins (i.e., B-factors). We showed that our 
sequence-based GNM model was able to recapitulate the mean-square fluctuations (B-
factors) produced by the original GNM. Our estimates of B-factors for a proteome-wide 
set of proteins exhibited an impressive correlation with the structure GNM. Moreover, 
our estimated B-factors were in good agreement with crystallographic B-factors for many 
cases. To address the issue of how protein dynamics can assess the impact of nSNVs 
occurring across the genome where there are no known 3D structures, we tested the 
ability of our predicted dynamics from the sequence GNM to assess nSNV phenotypes. 
For a large set of 738 nSNVs, the predicted B-factors using the sequence GNM was able 
to discriminate between disease and neutral nSNVs. A plot of the observed-to-expected 
ratio of the predicted B-factors revealed distributions of disease and neutral nSNVs that 
are remarkably similar to those in a previous DFI analysis (Nevin Gerek et al., 2013). 
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This preliminary analysis shows that the sequence GNM approach makes it now possible 
to obtain estimates of dynamics without the use of a 3D structure, which allows for the 
plausible integration of conformational dynamics into large-scale analysis of genomic 
variants.  
6.2 Future Directions 
 The research on protein conformational dynamics presented in this thesis can be 
exploited in the field of genomic medicine. Many of the current approaches to developing 
novel therapeutic drugs to treat diseases employ the concept of allostery. The ability to 
observe changes in conformational dynamics of specific regions of a protein in response 
to an event at a distance location (e.g. the binding of a substrate) is valuable for the 
development of novel drugs that act on proteins using allostery. Our dynamics-based 
metrics (DFI and DCI) make it possible to monitor changes in site-specific 
conformational dynamics due to external perturbations such as mutations or approaching 
ligands. In addition, they allow for identification of crucial allosteric regulation networks 
that are critical for maintaining protein function. Thus, site-specific conformational 
dynamics can be leveraged to investigate potential drug targets for novel therapeutic 
strategies. It has applications to genomics to systematically quantify and assess sites on a 
protein that are more, or less susceptible to harboring a harmful nSNV that may lead to 
disease. Moreover, the ability to estimate dynamics without a structure expands the 
breadth of its utility across the entire genome, such that it can compliment evolutionary 
methods regardless of whether the structure is known. As the cost of sequencing 
individual genomes is rapidly decreasing, complimentary metrics to assess human 
variations are especially enticing. Overall, the in silico tools proposed in this thesis can be 
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used with current approaches in genomic medicine to increase the efficacy of systematic 
assessments of an individual’s disease risk based on their genome, as well as determine 
specialized treatment plans in personalized medicine that are tailored to each individual. 
 The characterization of 3D folded structures using through experimental methods 
(e.g., X-ray crystallography) remains essential for mechanistic understanding biological 
function of proteins (Shi, 2014). A problem in this area is that many crystal structures are 
low-resolution (e.g., worse than 4 Å) as they exhibit weak diffraction patterns, resulting 
in poor quality electron density maps. Methods to refine these low-resolution structures 
have been proposed, including using known homologous structures as a constraint to 
enhance the quality of electron density maps (Schröder et al., 2010). Moreover, recent 
advances in single-particle electron cryo-microscopy (cryo-EM) is showing promise for 
obtaining higher resolution structures and complementing crystallography (Cheng, 2015). 
Our sequence-GNM method, which only requires an amino acid sequence to estimate the 
thermal motions of C-alpha atoms, may be used as an additional model to fit X-ray 
diffraction data to enhance the otherwise poor quality electron density maps. Thus, this 
could be applied to further complement current refinement methods for low-resolution 
diffraction data. 
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